Leafly (LFLY) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39119
Entity Registrant Name	Leafly Holdings, Inc. /DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-2266022
Entity Address, Address Line One	113 Cherry Street, PMB 88154
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98104-2205
City Area Code	206
Local Phone Number	455-9504
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		40,035,568
Entity Central Index Key	0001785592
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock, $0.0001 Par Value
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, $0.0001 Par Value
Trading Symbol	LFLY
Security Exchange Name	NASDAQ
Warrants, exercisable for shares of common stock at an exercise price of $11.50 per share
Entity Listings [Line Items]
Title of 12(b) Security	Warrants, exercisable for shares of common stockat an exercise price of $11.50 per share
Trading Symbol	LFLYW
Security Exchange Name	NASDAQ

CONSOLIDATED BALANCE SHEETS - U

CONSOLIDATED BALANCE SHEETS - UNAUDITED - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 27,829	$ 28,565
Accounts receivable, net of allowance for doubtful accounts of $958 and $1,848, respectively	2,610	2,958
Deferred transaction costs	0	2,840
Prepaid expenses and other current assets	3,569	1,347
Restricted cash	607	130
Total current assets	34,615	35,840
Property, equipment, and software, net	2,213	313
Total assets	36,828	36,153
Current liabilities
Accounts payable	1,375	3,048
Accrued expenses and other current liabilities	5,076	8,325
Deferred revenue	2,052	1,975
Current portion of convertible promissory notes, net	0	31,377
Total current liabilities	8,503	44,725
Non-current liabilities
Non-current portion of convertible promissory notes, net	28,726	0
Total non-current liabilities	29,723	0
Commitments and contingencies (Note 8)
Stockholders' deficit
Preferred stock; $0.0001 par value; 5,000 and 6,578 authorized, — and 6,140 issued and outstanding, and aggregate liquidation preference of $— and $19,436 at September 30, 2022 and December 31, 2021, respectively	0	1
Common stock; $0.0001 par value; 200,000 and 69,361 authorized at September 30, 2022 and December 31, 2021, respectively; 43,052 issued at September 30, 2022 and 25,086 shares issued and outstanding at December 31, 2021	4	3
Treasury stock, at cost; 3,081,086 and — shares held at at September 30, 2022 and December 31, 2021, respectively	(31,663)	0
Additional paid-in capital	89,194	61,194
Accumulated deficit	(58,933)	(69,770)
Total stockholders' deficit	(1,398)	(8,572)
Total liabilities and stockholders' deficit	36,828	36,153
Private warrants derivative liability
Non-current liabilities
Derivative liability	662	0
Escrow shares derivative liability
Non-current liabilities
Derivative liability	47	0
Stockholder earn-out rights derivative liability
Non-current liabilities
Derivative liability	$ 288	$ 0

CONSOLIDATED BALANCE SHEETS -_2

CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 958	$ 1,848
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	5,000,000	6,578,000
Preferred stock, issued (in shares)	0	6,140,000
Preferred stock, outstanding (in shares)	0	6,140,000
Preferred stock, aggregate liquidation preference	$ 0	$ 19,436
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	200,000,000	69,361,000
Common stock, issued (in shares)	43,052,000	25,086,000
Common stock, outstanding (in shares)		25,086,000
Treasury stock (in shares)	3,081,086	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 11,781	$ 10,896	$ 35,251	$ 30,959
Cost of revenue	1,515	1,261	4,411	3,564
Gross profit	10,266	9,635	30,840	27,395
Operating expenses
Sales and marketing	6,403	4,999	21,529	13,148
Product development	3,406	3,522	10,927	9,905
General and administrative	6,489	4,949	20,730	10,485
Total operating expenses	16,298	13,470	53,186	33,538
Loss from operations	(6,032)	(3,835)	(22,346)	(6,143)
Interest expense, net	(705)	(590)	(2,119)	(698)
Change in fair value of derivatives	22,264	0	36,264	0
Other expense, net	(73)	(29)	(962)	(39)
Net income (loss)	$ 15,454	$ (4,454)	$ 10,837	$ (6,880)
Net income (loss) per share:
Basic (in usd per share)	$ 0.43	$ (0.18)	$ 0.31	$ (0.28)
Diluted (in usd per share)	$ 0.28	$ (0.18)	$ 0.27	$ (0.28)
Weighted average shares outstanding:
Basic (in shares)	35,580	24,923	35,260	24,832
Diluted (in shares)	43,215	24,923	38,704	24,832

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - UNAUDITED - USD ($) shares in Thousands, $ in Thousands	Total	2021 Notes	Preferred Stock	Common Stock	Common Stock 2021 Notes	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital 2021 Notes	Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2020			6,140	24,752
Balance at the beginning at Dec. 31, 2020	$ 2,069		$ 1	$ 2			$ 59,812		$ (57,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,109)								(1,109)
Stock-based compensation	181						181
Exercise of stock options (in shares)				36
Exercise of stock options	40						40
Balance at the end (in shares) at Mar. 31, 2021			6,140	24,788
Balance at the end at Mar. 31, 2021	1,181		$ 1	$ 2			60,033		(58,855)
Balance at the beginning (in shares) at Dec. 31, 2020			6,140	24,752
Balance at the beginning at Dec. 31, 2020	2,069		$ 1	$ 2			59,812		(57,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(6,880)
Balance at the end (in shares) at Sep. 30, 2021			6,140	24,979
Balance at the end at Sep. 30, 2021	(3,832)		$ 1	$ 2			60,791		(64,626)
Balance at the beginning (in shares) at Mar. 31, 2021			6,140	24,788
Balance at the beginning at Mar. 31, 2021	1,181		$ 1	$ 2			60,033		(58,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,317)								(1,317)
Stock-based compensation	340						340
Exercise of stock options (in shares)				49
Exercise of stock options	68						68
Balance at the end (in shares) at Jun. 30, 2021			6,140	24,837
Balance at the end at Jun. 30, 2021	272		$ 1	$ 2			60,441		(60,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,454)								(4,454)
Stock-based compensation	208						208
Exercise of stock options (in shares)				142
Exercise of stock options	142						142
Balance at the end (in shares) at Sep. 30, 2021			6,140	24,979
Balance at the end at Sep. 30, 2021	(3,832)		$ 1	$ 2			60,791		(64,626)
Balance at the beginning (in shares) at Dec. 31, 2021			6,140	25,086
Balance at the beginning at Dec. 31, 2021	(8,572)		$ 1	$ 3			61,194		(69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(19,376)								(19,376)
Stock-based compensation	1,924						1,924
Exercise of stock options (in shares)				114
Exercise of stock options	127						127
Conversion of stock (in shares)			6,140	6,140	4,128
Conversion of stock	0	$ 33,024	$ (1)	$ 1				$ 33,024
Merger and recapitalization, net of fees (in shares)				2,007
Merger and recapitalization, net of fees	27,997						27,997
Stockholder contribution for debt issuance costs	924						924
Escrow shares derivative liability (in shares)				1,625
Escrow shares derivative liability	(6,867)						(6,867)
Private warrants derivative liability	(3,916)						(3,916)
Forward share purchase agreement derivative liability (in shares)				3,861
Forward share purchase agreement derivative liability	(14,170)						(14,170)
Stockholder earnout rights derivative liability	(26,131)						(26,131)
Balance at the end (in shares) at Mar. 31, 2022			0	42,961
Balance at the end at Mar. 31, 2022	(15,036)		$ 0	$ 4			74,106		(89,146)
Balance at the beginning (in shares) at Dec. 31, 2021			6,140	25,086
Balance at the beginning at Dec. 31, 2021	(8,572)		$ 1	$ 3			61,194		(69,770)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	10,837
Balance at the end (in shares) at Sep. 30, 2022			0	43,052		3,081
Balance at the end at Sep. 30, 2022	(1,398)		$ 0	$ 4		$ (31,663)	89,194		(58,933)
Balance at the beginning (in shares) at Mar. 31, 2022			0	42,961
Balance at the beginning at Mar. 31, 2022	(15,036)		$ 0	$ 4			74,106		(89,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	14,759								14,759
Stock-based compensation	464						464
Exercise of stock options (in shares)				29
Exercise of stock options	30						30
Balance at the end (in shares) at Jun. 30, 2022			0	42,990		0
Balance at the end at Jun. 30, 2022	217		$ 0	$ 4		$ 0	74,600		(74,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	15,454								15,454
Shares canceled (in shares)				(25)
Stock-based compensation	771						771
Exercise of stock options (in shares)				1
Exercise of stock options	1						1
Vesting of restricted stock units (in shares)				86
Settlement of forward share purchase agreement derivative liability	(17,841)						(17,841)
Purchase of treasury stock (in shares)						(3,081)
Purchase of treasury stock	0					$ (31,663)	31,663
Balance at the end (in shares) at Sep. 30, 2022			0	43,052		3,081
Balance at the end at Sep. 30, 2022	$ (1,398)		$ 0	$ 4		$ (31,663)	$ 89,194		$ (58,933)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income (loss)	$ 10,837	$ (6,880)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	276	195
Stock-based compensation expense	3,159	729
Bad debt expense	1,023	841
Noncash lease costs	0	230
Noncash amortization of debt discount	369	0
Noncash interest expense associated with convertible debt	243	710
Noncash change in fair value of derivatives	(36,264)	0
Other	15	44
Changes in operating assets and liabilities:
Accounts receivable	(675)	(674)
Prepaid expenses and other current assets	(2,222)	(600)
Accounts payable	173	(3)
Accrued expenses and other current liabilities	(2,141)	1,713
Deferred revenue	77	594
Net cash used in operating activities	(25,130)	(3,101)
Cash flows from investing activities
Additions of property, equipment, and software	(2,194)	(38)
Net cash used in investing activities	(2,194)	(38)
Cash flows from financing activities
Proceeds from exercise of stock options	158	223
Proceeds from convertible promissory notes	29,374	31,470
Proceeds from business combination placed in escrow and restricted	39,032	0
Trust proceeds received from recapitalization at closing	582	0
Repurchase of common stock and settlement of forward purchase agreements	(31,303)	0
Transaction costs associated with recapitalization	(10,761)	0
Payments on related party payables	(17)	(242)
Net cash provided by financing activities	27,065	31,451
Net (decrease) increase in cash, cash equivalents, and restricted cash	(259)	28,312
Cash, cash equivalents, and restricted cash, beginning of period	28,695	4,934
Cash, cash equivalents, and restricted cash, end of period	28,436	33,246
Supplemental disclosure of non-cash financing activities
Stockholder contribution for debt issuance costs	924	0
Repurchase of common stock in other accrued expenses	360	0
Conversion of promissory notes into common stock	33,024	0
Issuance of forward share purchase agreements	14,170	0
Issuance of private warrants	3,916	0
Issuance of sponsor shares subject to earnout conditions	6,867	0
Issuance of stockholder earn-out rights	$ 26,131	$ 0

Description of the Business and

Description of the Business and Merger Transaction	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Business and Merger Transaction	Description of the Business and Merger Transaction Description of the Business Leafly Holdings, Inc. (“Leafly” or “the Company”) is a leading online cannabis discovery marketplace and resource for cannabis consumers. Leafly provides an information resource platform with a deep library of content, including detailed information about cannabis strains, retailers and current events. Leafly was incorporated in the state of Delaware on June 20, 2019 and is headquartered in Seattle, Washington. The Company has two wholly-owned subsidiaries, Leafly Canada Ltd. (“Leafly Canada”) and Leafly, LLC (“Legacy Leafly”). Legacy Leafly is the accounting predecessor of Leafly. The accompanying condensed consolidated financial statements include the financial results of the Company and its wholly-owned subsidiaries. Merger with Merida On February 4, 2022, Leafly consummated the previously announced Mergers and related transactions (collectively, the “Merger”) pursuant to the Agreement and Plan of Merger dated August 9, 2021 and amended on September 8, 2021 and on January 11, 2022 (as amended, the “Merger Agreement”). Legacy Leafly (formerly known as Leafly Holdings, Inc.) entered into the Merger Agreement with Merida Merger Corp. I (“Merida”), Merida Merger Sub, Inc., a Washington corporation (“Merger Sub I”), Merida Merger Sub II, LLC, a Washington limited liability company (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”). Merger Sub I merged with and into Legacy Leafly, with Legacy Leafly surviving as a wholly-owned subsidiary of Merida, and following the initial Merger and as part of a single integrated transaction with the initial Merger, Legacy Leafly merged with and into Merger Sub II, with Merger Sub II surviving as a wholly-owned subsidiary of Merida. As a result of these Mergers, Legacy Leafly became a wholly owned subsidiary of Merida and was renamed Leafly, LLC, Merida was renamed Leafly Holdings, Inc. (“New Leafly”), and the securityholders of Legacy Leafly became security holders of Merida. We sometimes refer to the Mergers described above and the other transactions contemplated by the Merger Agreement and the other agreements being entered into by Merida and Legacy Leafly in connection with the Mergers as the “Business Combination” and to Merida following the Business Combination as “New Leafly.” While the legal acquirer in the Business Combination is Merida, for financial accounting and reporting purposes under U.S. GAAP, Legacy Leafly is the accounting acquirer with the Merger accounted for as a “reverse recapitalization.” A reverse recapitalization does not result in a new basis of accounting, and the financial statements of the combined entity represent the continuation of the financial statements of Legacy Leafly. Under this accounting method, Merida is treated as the “ acquired ” company and Legacy Leafly is the accounting acquirer, with the transaction treated as a recapitalization of Legacy Leafly. Merida’s assets, liabilities and results of operations were consolidated with Legacy Leafly’s beginning on the date of the Business Combination. Except for certain derivative liabilities, the assets and liabilities of Merida were recognized at historical cost (which is consistent with carrying value) and were not material, with no goodwill or other intangible assets recorded. The derivative liabilities, which are discussed in Notes 12 and 13, were recorded at fair value. The consolidated assets, liabilities, and results of operations of Legacy Leafly became the historical financial statements, and operations prior to the closing of the Business Combination presented for comparative purposes are those of Legacy Leafly. Pre-Merger shares of common stock and preferred stock were converted to shares of common stock of the combined company using the conversion ratio of 0.3283 and for comparative purposes, the shares and net loss per share of Legacy Leafly, prior to the Merger, have been retroactively restated using the conversion ratio. The following table provides a summary of the significant sources and uses of cash related to the closing of the Business Combination on February 4, 2022 and the cash received from escrow through September 30, 2022: Amount in Merida's trust account ("the Trust") at closing $ 90,824 Total payment to Merida public redeeming stockholders 49,466 Amount available after paying Merida redeeming stockholders 41,358 Cash to escrow for Forward Share Purchase Agreements (see Note 13) 39,032 Remaining balance 2,326 Merida expenses paid from the Trust at closing 1,744 Net cash from the Trust to Leafly at closing 582 Cash received from escrow February 4, 2022 - September 30, 2022 8,089 Net cash from the Trust to Leafly as of September 30, 2022 $ 8,671 The following table provides a reconciliation of the common shares related to the Merger transaction: Merida public stockholders 4,160 Merida initial stockholders (including Sponsor and EarlyBirdCapital) 1,667 Holders of 2022 Notes (see Note 11) 38 Shares held by Sponsor in escrow that are subject to earn-out conditions (see Note 12) 1,625 Total Merida 7,490 Legacy Leafly existing securityholders 35,434 Total shares outstanding as of February 4, 2022 42,924 All shares in this table, except the shares held by Merida public stockholders and Holders of 2022 Notes, were subject to restrictions as to trading through August 3, 2022 ("Lock Up Restrictions").

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	Basis of Presentation and Significant Accounting Policies Basis of Presentation The interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ( “ GAAP ” ) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting and should be read in conjunction with the Company's audited consolidated financial statements for the years ended December 31, 2021 and 2020, and Management’s Discussion and Analysis of Financial Condition and Results of Operations of Leafly for the year ended December 31, 2021, each of which was filed on the company’s Amendment No. 1 on Form 8-K/A filed with the SEC on March 31, 2022 (the “2021 Financial Information”). These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions. The results of operations for any interim periods are not necessarily indicative of the results that may be expected for the entire fiscal year or any other interim period. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted in accordance with the rules and regulations of the SEC for interim reporting. All intercompany balances and transactions have been eliminated upon consolidation. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reporte d net income (loss). Seasonality We may experience seasonality in our business, which we believe has moderate impacts on our overall revenue. In certain years, we've seen seasonal fluctuations that coincide with either federal holidays, generally in the fourth quarter, or industry holidays and events, generally in the spring. Our industry and business history is limited and therefore we can't be certain that these are known trends or that other trends may develop. Emerging Growth Company Status Leafly is an emerging growth company (“EGC”), as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). Under the JOBS Act, EGCs can delay adopting new or revised accounting standards issued until such time as those standards apply to private companies. The Company has elected to use this extended transition period. In providing this relief, the JOBS Act does not preclude the Company from adopting a new or revised accounting standard earlier than the time that such standard applies to private companies. Leafly will continue to use this relief until the earlier of the date that it (a) is no longer an emerging growth company or (b) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. Significant Accounting Policies The unaudited interim financial statements should be read in conjunction with the Company's 2021 Financial Information, which describes the Company's significant accounting policies. There have been no material changes to the Company's significant accounting policies during the three and nine months ended September 30, 2022 compared to our Annual Report on Form 10-K for the year ended December 31, 2021. However, certain items became material during the periods presented and therefore, we have disclosed the related accounting policies below. In addition, as a result of the Business Combination, the Company entered into certain derivative instruments that are accounted for as liabilities. These instruments and the related accounting are discussed in Notes 12, 13, and 20. Capitalized Software The Company capitalizes certain costs related to acquisition and development of software for internal use, including internal labor costs incurred during development. The Company begins to capitalize these costs when planning and design efforts are successfully completed and development is ready to commence. Costs incurred during planning and design, together with costs incurred for training and maintenance, are expensed as incurred and recorded in product development expense. The Company places capitalized software assets into service and commences amortization when the asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying costs of specified upgrades or enhancements to the assets when the upgrade or enhancement will result in new or additional functionality. The Company’s estimated useful life for capitalized software is 3 years, and amortization is calculated using the straight-line method. The Company considers the useful life of capitalized software to be a significant estimate. Transaction Costs The Company incurred significant costs direct and incremental to the Business Combination and therefore to the recapitalization of the Company. We deferred such costs incurred in 2021. In 2022, upon closing of the Business Combination, total direct transaction costs were allocated between equity and liability instruments measured at fair value on a recurring basis that were newly issued in the recapitalization. Amounts allocated to equity were recorded to additional paid-in capital, while amounts allocated to the specified liabilities were recorded as other expense. Recent Accounting Pronouncements As a result of the elected JOBS Act relief discussed above, these condensed consolidated financial statements may not be comparable to other companies that do not elect JOBS Act relief or choose to adopt certain accounting pronouncements during a different period than the Company. Recently Adopted Accounting Standards None. Accounting Pronouncements Issued But Not Yet Adopted

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	9 Months Ended
	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash Cash, cash equivalents, and restricted cash consisted of the following: September 30, December 31, Cash and cash equivalents $ 27,829 $ 28,565 Restricted cash 607 130 $ 28,436 $ 28,695 The September 30, 2022 restricted cash balance includes $360 of cash maintained in escrow related to Forward Share Purchase Agreements ("FPAs"). Effective August 1, 2022, the FPA holders elected to have Leafly repurchase their remaining 3,081 shares covered by the FPAs for an aggregate repurchase price of $31,663. As a result, the shares repurchased have been removed from Leafly's outstanding shares effective as of the date of purchase and placed into treasury. The FPA holders elected to have all but $360 disbursed from the escrow account and are able to claim the remainder any time until August 1, 2023. If unclaimed, the remaining funds in escrow will be distributed to the Company. Additional information regarding the FPAs is included in Notes 13 and 20.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following: September 30, December 31, Prepaid insurance $ 2,065 $ 57 Other prepaid expenses 1,441 1,134 Other current assets 63 156 $ 3,569 $ 1,347

Accounts Receivable, Net

Accounts Receivable, Net	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Accounts Receivable, Net	Accounts Receivable, Net Accounts receivable, net consists of amounts due from customers less an allowance for doubtful accounts. The following table presents the allowance for doubtful accounts and the changes therein: Three Months Ended Nine Months Ended September 30, 2022 2021 2022 2021 Balance, beginning of period $ 1,469 $ 1,142 $ 1,848 $ 1,131 Add: provision for doubtful accounts, net of recoveries 383 529 1,023 841 Less: write-offs (894) (93) (1,913) (394) Balance, end of period $ 958 $ 1,578 $ 958 $ 1,578

Property, Equipment and Softwar

Property, Equipment and Software, Net	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Equipment and Software, Net	Property, Equipment, and Software, Net Property, equipment, and software consisted of the following: September 30, December 31, Furniture and equipment $ 902 $ 1,049 Leasehold improvements — 2 Internal-use software 2,081 — 2,983 1,051 Less: accumulated depreciation and amortization (770) (738) $ 2,213 $ 313 The Company recognized depreciation expense of $38 a nd $57 for the three months ended September 30, 2022 and 2021, respectively, and $135 and $195 for the nine months ended September 30, 2022 and 2021, respectively. Amortization of internal-use software was $90 and $0 for the three months ended September 30, 2022 and 2021, respectively, and $141 and $0 for the nine months ended September 30, 2022 and 2021, respectively. Leases

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses consist of the following: September 30, December 31, Accrued bonuses $ 537 $ 3,668 Other employee-related liabilities 2,547 2,131 Accrued interest 400 1,313 Other accrued expenses 1 1,592 1,213 $ 5,076 $ 8,325 1 There are no individual items within this balance that exceed 10% of the total of the table.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitment and Contingencies	Commitments and ContingenciesIn the normal course of business, the Company may receive inquiries or become involved in legal disputes regarding various litigation matters. In the opinion of management, any potential liabilities resulting from such claims would not have a material adverse effect on the Company’s condensed consolidated financial statements.

Revenue and Contract Balances

Revenue and Contract Balances	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue and Contract Balances	Revenue and Contract Balances The following table presents the Company's revenue by service type: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Advertising $ 11,731 $ 10,840 $ 34,959 $ 30,813 Other services 50 56 292 146 $ 11,781 $ 10,896 $ 35,251 $ 30,959 The following table presents the Company's revenue by geographic region: Three Months Ended Nine Months Ended 2022 2021 2022 2021 United States 1 $ 11,140 $ 9,757 $ 32,787 $ 27,644 All other countries 1 641 1,139 2,464 3,315 $ 11,781 $ 10,896 $ 35,251 $ 30,959 1 Calculated based on customer sold to address for the periods presented. Using the prior calculation based on billing entity address, revenue for the United States and All other countries would have been $11,335 and $446 for the three months ended September 30, 2022, $10,041 and $855 for the three months ended September 30, 2021, $33,491 and $1,760 for the nine months ended September 30, 2022, and $28,204 and $2,755 for the nine months ended September 30, 2021, respectively. The following tables presents the Company's revenue by state: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Arizona 19 % 16 % 18 % 16 % California 13 % 11 % 11 % 10 % Oregon 10 % 11 % 10 % 12 % No other state comprised 10% or more of Leafly’s revenue during the three and nine months ended September 30, 2022 and 2021. We have a diversified set of customers; no single customer accounted for 10% or more of our revenue for the three and nine months ended September 30, 2022 and 2021. The following table presents the Company's revenue by timing of recognition: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Over time Retail 1 $ 9,042 $ 8,606 $ 27,286 $ 24,572 Brands 2 1,759 1,581 5,067 4,591 $ 10,801 $ 10,187 $ 32,353 $ 29,163 Point in time Brands 3 980 709 2,898 1,796 $ 11,781 $ 10,896 $ 35,251 $ 30,959 1 Revenues from subscription services and display ads. 2 Revenues from brand profile subscriptions and digital media (including display ads and audience extension). 3 Revenues from branded content and channel advertising (including direct to consumer email). Revenues recognized over time are associated with software subscriptions, display ads and audience extension. Revenues recognized at a point in time are associated with branded content and channel advertising. There are no material variations in delivery and revenue recognition periods within the over time category. Contract liabilities consist of deferred revenue, which is recorded on the Consolidated Balance Sheets when the Company has received consideration, or has the right to receive consideration, in advance of transferring the performance obligations under the contract to the customer. The following table presents the Company's deferred revenue accounts and changes in the deferred revenue accounts Three Months Ended Nine Months Ended 2022 2021 2022 2021 Balance, beginning of period $ 2,467 $ 2,079 $ 1,975 $ 1,585 Add: net increase in current period contract liabilities 1,630 1,947 1,976 2,112 Less: revenue recognized from beginning balance (2,045) (1,847) (1,899) (1,518) Balance, end of period $ 2,052 $ 2,179 $ 2,052 $ 2,179 A majority of the deferred revenue balance as of September 30, 2022 is expected to be recognized in the subsequent 12-month period. No other contract assets or liabilities are recorded on the Company’s Consolidated Balance Sheets as of September 30, 2022 or December 31, 2021.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rate was 0% for the three and nine months ended September 30, 2022 and 2021. The effective tax rate was lower than the U.S. federal statutory rate of 21% due to the Company’s full valuation allowance recorded against its deferred tax assets. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Convertible Promissory Notes	Convertible Promissory Notes 2022 Notes Merida entered into a $30,000 convertible note purchase agreement in January 2022, which Legacy Leafly subsequently guaranteed and joined as a party to the agreement on February 4, 2022 in connection with the Business Combination (the “2022 Notes”). Accordingly, post-Business Combination, the 2022 Notes are presented as a liability on Leafly's balance sheet, net of debt issuance costs and debt discount. The Company recognized debt issuance costs of $714 paid in cash, and a debt discount of $924 paid in shares transferred by the Sponsor to the holders of the 2022 Notes upon issuance. The 2022 Notes bear interest at 8% annually, paid in cash semi-annually in arrears on July 31 and January 31 of each year, and mature on January 31, 2025. The 2022 Notes are unsecured convertible senior notes due 2025. They are convertible at the option of the holders at any time before maturity at an initial conversion share price of $12.50. In addition, the Company may, at its election, force the conversion of the 2022 Notes on or after January 31, 2024, if the volume-weighted average trading price of the Company’s common stock exceeds $18.00 for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days. The Company also has the option, on or after January 31, 2023 and prior to the 40th trading day immediately before the maturity date and subject to the holders’ ability to optionally convert, to redeem all or a portion of the 2022 Notes at a cash redemption price equal to 100% of the principal amount of the 2022 Notes, plus accrued and unpaid interest, if any. The holders of the 2022 Notes have the right to cause the Company to repurchase for cash all or a portion of the 2022 Notes held by such holder upon the occurrence of a “fundamental change” (as defined) or in connection with certain asset sales, in each case at a price equal to 100% of par plus accrued and unpaid interest, if any. As of September 30, 2022, the net carrying amount of the 2022 Notes was $28,726, which includes unamortized issuance costs and debt discount of $1,274. The estimated fair value of the convertible debt instruments was approximately $23,000 as of September 30, 2022. The fair value was measured using a combination of an income approach and Black-Scholes model, both of which are considered Level 3 inputs in the fair value hierarchy. 2021 Notes Legacy Leafly issued a series of convertible promissory notes in June 2021 totaling approximately $23,970. In August 2021, Legacy Leafly issued additional convertible promissory notes totaling $7,500 to Merida Capital, an affiliate of Merida. (Both note issuances are collectively referred to below as the “2021 Notes”). The 2021 Notes bore interest at 8% annually and were considered traditional convertible debt with the entire amount recognized as a liability (with no amount allocated to equity), reduced for direct issuance costs, with initial and subsequent recognition at amortized cost in accordance with the interest method. Unless converted, the entire balance of principal and accrued but unpaid interest was due on December 3, 2022. The 2021 Notes were contingently convertible upon the occurrence of certain events, to include a qualified financing, a non-qualified financing, or in a qualified public transaction. On February 4, 2022, in connection with the Business Combination, the 2021 Notes were converted to approximately 4,128 shares of Leafly common stock at the conversion price of approximately $2.63, which was 80% of the implied price per share of common stock in the Business Combination. Upon closing of the Business Combination, the shares of common

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity The Consolidated Statements of Changes in Stockholders' Equity (Deficit) reflect the reverse recapitalization on February 4, 2022, as discussed in Note 1. Since the Company was determined to be the accounting acquirer in the transaction, all periods presented prior to consummation of the transaction reflect the historical activity and balances of Leafly, Inc. (other than common and preferred stock and potentially issuable shares underlying stock options and convertible promissory notes, which have been retroactively restated). Common Stock On February 4, 2022, the Business Combination was consummated pursuant to the Merger Agreement. Prior to the Business Combination, Legacy Leafly's capital stock consisted of Series A preferred stock and common stock. Upon the consummation of the Business Combination, all issued and outstanding shares of Series A preferred stock converted to shares of nonredeemable common stock. As of September 30, 2022 Leafly's authorized capital stock consisted of: • 200,000 shares of Leafly common stock, $0.0001 par value per share; and • 5,000 shares of Leafly preferred stock, $0.0001 par value per share. Voting Rights The holders of Leafly common stock exclusively possess all stockholder voting power with respect to Leafly, except as otherwise required by law or the Company's charter. Holders of Leafly common stock are entitled to one vote per share on each matter properly submitted to a vote of stockholders. The holders of Leafly common stock will at all times vote together as one class on all matters submitted to a vote of stockholders, unless otherwise required by Delaware law or the charter. If Leafly has multiple classes of common stock in the future, then Delaware law could require holders of shares of a class of capital stock to vote separately as a single class in the following circumstances: • if we were to seek to amend the charter to increase or decrease the par value of a class of the capital stock, then that class would be required to vote separately to approve the proposed amendment; and • if we were to seek to amend the charter in a manner that alters or changes the powers, preferences, or special rights of a class of capital stock in a manner that affected its holders adversely, then that class would be required to vote separately to approve the proposed amendment. Election of Directors The charter provides for a classified board of directors that is divided into three classes with staggered three-year terms. Only the directors in one class are subject to election by a plurality of the votes cast at each annual meeting of stockholders, with the directors in the other classes continuing for the remainder of their respective three-year terms. The charter does not provide for cumulative voting for the election of directors. Dividend Rights Subject to the rights, if any, of the holders of any outstanding series of the Leafly preferred stock, the holders of Leafly common stock are entitled to receive dividends and other distributions (payable in cash, property or capital stock of Leafly) when, as and if declared by the Leafly board of directors out of any assets or funds legally available and will share equally on a per share basis in such dividends and distributions. No Preemptive or Similar Rights Leafly common stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions. Liquidation, Dissolution and Winding Up In the event of any voluntary or involuntary liquidation, dissolution or winding-up, after payment or provision for payment of the debts and other liabilities of Leafly, the holders of Leafly common stock will be entitled to receive all the remaining assets of Leafly available for distribution to its stockholders, ratably in proportion to the number of shares of the Leafly common stock held by them, subject to the rights, if any, of the holders of any outstanding shares of Leafly preferred stock. Sponsor Shares Subject to Earn-Out Conditions In accordance with the Merger Agreement, upon closing of the Business Combination, 1,625 of the shares held by the Sponsor were placed in escrow and subjected to earn-out conditions ("Escrow Shares"). Of these Escrow Shares, 50% will be released from escrow if and when the Company's common stock trades at or above $13.50 at any time during the two-year period following closing, and the remaining 50% will be released from escrow if and when the Company's common stock trades at or above $15.50 at any time during the three-year period following closing. In addition, all 1,625 Escrow Shares will be released upon a change in control. We account for the Escrow Shares as derivative liabilities, remeasured to fair value on a recurring basis, with changes in fair value recorded to earnings. See Note 20 for additional information. Lock Up Restrictions In accordance with various legal documents, the majority of our Common Stock was subject to restrictions on trading through August 3, 2022. See Note 1 for detail on Common Stock previously subject to Lock Up Restrictions. Treasury Stock Effective August 1, 2022, the Company repurchased 3,081 shares of its common stock at a weighted-average price of $10.28 per share for a total of $31,663, with $31,303 paid with restricted cash and $360 remaining in accrued expenses and other current liabilities on our consolidated balance sheet at September 30, 2022. These repurchases were in settlement of the Forward Purchase Agreements. See Notes 3 and 13 for additional information. Stockholder Earn-Out Rights Leafly stockholders, as of immediately prior to the closing of the Business Combination, were granted upon closing of the Business Combination, contingent rights to receive up to 5,429 shares of common stock (the "Rights") if the Company achieves certain earn-out conditions prior to the third anniversary of the Business Combination. We will account for the Rights as derivative liabilities, which we will remeasure to their current fair value as of the end of each reporting period, with changes in the fair value recorded to earnings. See Note 20 for additional information. The Rights will be earned and shares of common stock will be issued as follows: First Tranche Up to 2,715 shares will be issued if and when: • revenue for the year ending December 31, 2022 equals or exceeds $65,000 (first revenue target), or • the date on which the volume-weighted average price of common stock for a period of at least 20 days out of 30 consecutive trading days ending on the trading day immediately prior to the date of determination is greater than or equal to $13.50 during the two-year period beginning on the trading day after the closing date of the Merger (as adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to shares of common stock occurring at or after the Closing), or • a change of control occurs within the two years after the closing date of the Business Combination at the first target price or higher, or • a pro rata portion of 2,715 shares (50%) if the revenue during the target period meets or exceeds 90% of the first revenue target. Second Tranche Up to 2,715 shares will be issued if and when: • revenue for the year ending December 31, 2023 equals or exceeds $101,000 (second revenue target), or • the date on which the volume-weighted average price of common stock for a period of at least 20 days out of 30 consecutive trading days ending on the trading day immediately prior to the date of determination is greater than or equal to $15.50 during the three-year period beginning on the trading day after the closing date of the Merger (as adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to shares of common stock occurring at or after the Closing), or • a change of control occurs within the three years after the closing date of the Business Combination at the second target price or higher, or • a pro rata portion of 2,715 (50%) if the revenue during the second target period meets or exceeds 90% of the second revenue target. If the second revenue or price target is met in full, the respective first target will be deemed to have been met as well if it had not been met during the first period. Preferred Stock

Warrants and Forward Purchase S

Warrants and Forward Purchase Share Agreements	9 Months Ended
	Sep. 30, 2022
Other Liabilities Disclosure [Abstract]
Warrants and Forward Purchase Share Agreements	Warrants and Forward Share Purchase Agreements Public Warrants As of both September 30, 2022 and December 31, 2021, there were 6,501 warrants outstanding that had been included in the units issued in Merida’s initial public offering (the "Public Warrants"). Each Public Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a merger or (b) 12 months from the closing of the IPO. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a merger, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a merger or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption; • if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to the warrant holders; and • If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Private Warrants As of both September 30, 2022 and December 31, 2021, there were 3,950 warrants outstanding that Merida had sold to the Sponsor and EarlyBirdCapital in a private placement that took place simultaneously with Merida’s initial public offering ("the Private Warrants"). The Private Warrants are identical to the Public Warrants, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. We account for the Private Warrants as derivative liabilities, remeasured to fair value on a recurring basis, with changes in the fair value recorded to earnings. See Note 20 for additional information. Forward Share Purchase Agreements In December 2021 and January 2022, the Company entered into four separate FPAs with certain investors. The FPAs allowed the investors to sell and transfer common stock held by the investors, not to exceed a total of 4,000 shares in aggregate, to the Company in exchange for cash. The price to be paid by the Company was initially $10.16 per share for up to 2,600 shares and $10.01 per share for up to 1,400 shares. As required by the FPAs, $39,032 of cash was placed into escrow upon closing of the Business Combination, to be used for the share purchases. If the FPAs were not exercised by the holders within their terms of three months post-Business Combination closing, the associated funds were to be released from escrow to the Company. We account for the FPAs as derivative liabilities, remeasured to fair value on a recurring basis, with changes in the fair value recorded to earnings. On May 3, 2022, Leafly and the holders entered into amendments to the FPAs (the “Amended FPAs”). The Amended FPAs modified the price at which the applicable holder has the right, but not the obligation, to have Leafly repurchase certain shares held by the applicable holder as of the closing of the Business Combination and not later sold into the market to a price of $10.16 per share (with respect to 686 of the shares subject to the Amended FPAs) and $10.31 per share (with respect to 2,404 of the shares subject to the Amended FPAs). The Amended FPAs also modified the date by which such holders may elect to have Leafly repurchase their shares to August 1, 2022. In connection with the Amended FPAs, certain amendments were also made to the escrow agreements in respect to the escrow accounts. During the three and nine months ended September 30, 2022, $720 and $8,089, respectively, was released from the escrow accounts due to the FPA holders selling shares in the open market, which was accordingly reclassified on the Company's balance sheet from restricted cash to cash. Effective August 1, 2022, the FPA holders elected to have Leafly repurchase their remaining 3,081 shares covered by the FPAs for an aggregate repurchase price of $31,663. As a result, the shares repurchased have been removed from Leafly's outstanding shares effective as of the date of purchase and placed into treasury. The FPA holders elected to have all but $360 disbursed from the escrow account and are able to claim the remainder any time until August 1, 2023. If unclaimed, the remaining funds in escrow will be distributed to the Company. Also, in connection with the settlement, 25 shares held by Merida Holdings, LLC were canceled, according to an agreement between the Company and Merida Holdings, LLC entered into upon execution of the FPAs.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive PlansThe Company currently has four equity plans: the New Leafly 2021 Equity Incentive Plan (the “2021 Plan”), the Legacy Leafly 2018 Equity Incentive Plan (the “2018 Plan”), the New Leafy Earn Out Plan (“Earn Out Plan”), and the New Leafly 2021 Employee Stock Purchase Plan (the “ESPP”), which are discussed in this Note 14 and in Note 15. Awards under the 2021 Plan are detailed below. There were no options or other equity awards granted under the 2018 Plan during the three and nine months ended September 30, 2022. 2021 Plan The 2021 Plan became effective immediately upon closing of the Business Combination. Pursuant to the 2021 Plan, 4,502 shares of common stock were initially reserved for issuance. During the term of the 2021 Plan, the number of shares of common stock thereunder automatically increases on each January 1, commencing on January 1, 2023, and ending on (and including) January 1, 2031, by the lesser of (i) 10% of the fully diluted shares of common stock as of the last day of the preceding fiscal year and (ii) 4,502 shares (adjusted pursuant to the terms of the 2021 Plan). In August 2022, the Company’s compensation committee of the board of directors or an authorized executive of the Company granted stock options to purchase an aggregate of approximately 101 shares of common stock at an exercise price of $1.98 per share and granted 1,228 restricted stock units. Prior to such grants, no grants had been made under the 2021 Plan. See Note 21 for awards subsequent to September 30, 2022. The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. The following weighted-average assumptions were used as inputs to the pricing model for options granted during the three and nine months ended September 30, 2022: Risk-free interest rate 4.1 % Expected term in years 4.06 Expected volatility 74.6 % Expected dividend yield 0.0 % Stock option activity under the 2021 Plan for the three months ended September 30, 2022 (there were no stock options granted previously under this plan) was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at June 30, 2022 — $ — $ — — Granted 101 1.98 Exercised — — Forfeited or expired — — Outstanding at September 30, 2022 101 $ 1.98 $ — 9.89 Vested and exercisable — $ — $ — — As of September 30, 2022, there was $114 of total unrecognized compensation cost related to stock options granted under the 2021 Plan. That cost is expected to be recognized over a weighted-average period of 3.36 years. The weighted-average grant date fair value of options granted under the 2021 Plan for the three and nine months ended September 30, 2022 was $1.16 per share. Restricted stock unit activity under the 2021 Plan for the three months ended September 30, 2022 (there were no restricted stock units granted previously under this plan) was as follows: Number of Weighted Average Total Fair Value Unvested at June 30, 2022 — $ — Granted 1,228 1.98 $ 2,432 Vested (173) 1.98 $ 325 Forfeited (65) 1.98 Unvested at September 30, 2022 990 $ 1.98 As of September 30, 2022, there was $1,825 of total unrecognized compensation cost related to unvested restricted stock units granted under the 2021 Plan. That cost is expected to be recognized over a weighted-average period of 3.34 years. 2018 Plan The 2018 Plan became effective on April 17, 2018. The 2018 Plan terminated upon closing of the Business Combination in 2022, but then outstanding options under the 2018 Plan remain outstanding pursuant to their terms, with adjustments to the number of shares and exercise prices to reflect the terms of the Business Combination. In May 2021, the Company’s board of directors granted stock options under the 2018 Plan to purchase an aggregate of approximately 2,191 shares of common stock at an exercise price of $1.10 per share. The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. The following weighted-average assumptions were used as inputs to the pricing model for options granted during the nine months ended September 30, 2021 (there were no grants made in 2022): Risk-free interest rate 1.0 % Expected term in years 5.90 Expected volatility 61.2 % Expected dividend yield 0.0 % Stock option activity under the 2018 Plan for the quarterly periods ended September 30, 2022 was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at January 1, 2022 3,851 $ 1.77 Exercised (114) 1.12 Forfeited or expired (56) 1.08 Outstanding at March 31, 2022 3,681 $ 1.78 $ 23,918 8.62 Exercised (29) $ 1.05 Forfeited or expired (3) $ 2.30 Outstanding at June 30, 2022 3,649 $ 1.78 $ 11,307 8.35 Exercised (5) 0.79 Forfeited or expired (110) 7.75 Outstanding at September 30, 2022 1 3,534 $ 1.60 $ 84 8.29 Vested and exercisable 1,849 $ 1.18 $ 82 7.80 1 Includes 2,478, 0, and 1,056 of awards accounted for as service-based, performance-based, and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The performance options vest only if gross revenue equals or exceeds certain thresholds for the years ending December 31, 2022 and 2023, while the market-based options will vest only if the price of the Company's common stock reaches a $1,000,000 market capitalization target for any 20 days during a 30-day period on or before the fourth anniversary of the closing of the Merger. As of September 30, 2022, there was: (i) $1,219 of unrecognized compensation cost related to service-based awards, which is expected to be recognized over a weighted-average service period of approximately 2.13 years; and (ii) $1,687 of unrecognized compensation cost related to market-based awards, which is expected to be recognized over a weighted-average service period of approximately 1.55 years. The following tables presents the classification of stock-based compensation expense under the 2018 Plan and the 2021 Plan: Three Months Ended September 30, 2022 Nine Months Ended September 30, 2022 2021 2022 2021 Sales and marketing $ 77 $ 15 $ 137 $ 65 Product development 86 14 123 126 General and administrative 608 179 2,899 538 $ 771 $ 208 $ 3,159 $ 729 Earn Out Plan The Earn Out Plan became effective immediately upon closing of the Business Combination. Pursuant to the Earn Out Plan, approximately 571 shares of common stock have been reserved for issuance to employees and certain other eligible parties in the form of restricted stock units (“RSUs”). These RSUs will vest if the Company achieves certain thresholds prior to the third anniversary of the Merger. No RSUs have been awarded under the Earn Out Plan as of September 30, 2022. Option Modification Concurrent with the closing of the Business Combination, the vesting provisions of certain stock options previously granted in 2021 to our Chief Executive Officer to purchase 2,917 shares of common stock were modified, and a corresponding charge of $1,366 was recorded for the three months ended March 31, 2022 to general and administrative expenses and additional paid-in capital. The original award included the following vesting provisions: • Liquidity Event Option : A stock option to purchase 1,458 shares of common stock will vest upon the earlier of (a) the closing of the Initial Public Offering of the Company's common stock or (b) a change in control, provided the recipient remains in continuous service. • Milestone Option : A stock option to purchase 1,458 shares of common stock will vest one-third each upon the achievement of the three annual revenue targets of $75,000, $150,000 and $300,000, provided the recipient remains in continuous service. The modified vesting provisions are as follows: • Liquidity Event Option : A stock option to purchase 1,458 shares of common stock will vest as follows, provided the recipient remains in continuous service: 50% upon the closing of the Business Combination and 50% upon the earlier of (i) the Company's achievement of a $1,000,000 market capitalization for any 20 during a 30-day period on or before the fourth anniversary of the closing of the Business Combination (the "Market Cap Milestone") or (ii) a change in control. • Milestone Option : A stock option to purchase 1,458 shares of common stock will vest upon the achievement of the following milestones, provided that the recipient remains in continuous service: ◦ First Milestone : 50% of the total number of shares subject to the stock option will vest if the Company's gross revenue for the year ending December 31, 2022 equals or exceeds $65,000. A pro rata amount vests in the event that the Company's gross revenue equals or exceeds 90% of the revenue target. ◦ Second Milestone : 50% of the total number of shares subject to the stock option will vest if the Company's gross revenue for the year ending December 31, 2023 equals or exceeds $101,000. A pro rata amount vests in the event that the Company's gross revenue equals or exceeds 90% of the revenue target. ◦ In the event the Second Milestone is achieved, any unvested portion of the stock option subject to the First Milestone will fully vest. ◦ In the event the Market Cap Milestone is achieved, any unvested portion of the Milestone Option will fully vest. ◦ The date of vesting for the Milestone Option will be the earlier of (i) the date following the Company's filing with the SEC of its Form 10-K for the applicable fiscal year in which the applicable revenue target was attained or, (ii) the date of the Market Cap Milestone is achieved. ◦ All shares subject to the Milestone Option will vest immediately upon a change in control. ◦ The Milestone Option will remain outstanding unless and until the last possible time that the Second Milestone can be achieved, the Market Cap Milestone can be achieved, or a change in control may occur during the term of the Milestone Option award, subject to the recipient's continued service.

Employee Stock Purchase Plan

Employee Stock Purchase Plan	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Employee Stock Purchase Plan	Equity Incentive PlansThe Company currently has four equity plans: the New Leafly 2021 Equity Incentive Plan (the “2021 Plan”), the Legacy Leafly 2018 Equity Incentive Plan (the “2018 Plan”), the New Leafy Earn Out Plan (“Earn Out Plan”), and the New Leafly 2021 Employee Stock Purchase Plan (the “ESPP”), which are discussed in this Note 14 and in Note 15. Awards under the 2021 Plan are detailed below. There were no options or other equity awards granted under the 2018 Plan during the three and nine months ended September 30, 2022. 2021 Plan The 2021 Plan became effective immediately upon closing of the Business Combination. Pursuant to the 2021 Plan, 4,502 shares of common stock were initially reserved for issuance. During the term of the 2021 Plan, the number of shares of common stock thereunder automatically increases on each January 1, commencing on January 1, 2023, and ending on (and including) January 1, 2031, by the lesser of (i) 10% of the fully diluted shares of common stock as of the last day of the preceding fiscal year and (ii) 4,502 shares (adjusted pursuant to the terms of the 2021 Plan). In August 2022, the Company’s compensation committee of the board of directors or an authorized executive of the Company granted stock options to purchase an aggregate of approximately 101 shares of common stock at an exercise price of $1.98 per share and granted 1,228 restricted stock units. Prior to such grants, no grants had been made under the 2021 Plan. See Note 21 for awards subsequent to September 30, 2022. The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. The following weighted-average assumptions were used as inputs to the pricing model for options granted during the three and nine months ended September 30, 2022: Risk-free interest rate 4.1 % Expected term in years 4.06 Expected volatility 74.6 % Expected dividend yield 0.0 % Stock option activity under the 2021 Plan for the three months ended September 30, 2022 (there were no stock options granted previously under this plan) was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at June 30, 2022 — $ — $ — — Granted 101 1.98 Exercised — — Forfeited or expired — — Outstanding at September 30, 2022 101 $ 1.98 $ — 9.89 Vested and exercisable — $ — $ — — As of September 30, 2022, there was $114 of total unrecognized compensation cost related to stock options granted under the 2021 Plan. That cost is expected to be recognized over a weighted-average period of 3.36 years. The weighted-average grant date fair value of options granted under the 2021 Plan for the three and nine months ended September 30, 2022 was $1.16 per share. Restricted stock unit activity under the 2021 Plan for the three months ended September 30, 2022 (there were no restricted stock units granted previously under this plan) was as follows: Number of Weighted Average Total Fair Value Unvested at June 30, 2022 — $ — Granted 1,228 1.98 $ 2,432 Vested (173) 1.98 $ 325 Forfeited (65) 1.98 Unvested at September 30, 2022 990 $ 1.98 As of September 30, 2022, there was $1,825 of total unrecognized compensation cost related to unvested restricted stock units granted under the 2021 Plan. That cost is expected to be recognized over a weighted-average period of 3.34 years. 2018 Plan The 2018 Plan became effective on April 17, 2018. The 2018 Plan terminated upon closing of the Business Combination in 2022, but then outstanding options under the 2018 Plan remain outstanding pursuant to their terms, with adjustments to the number of shares and exercise prices to reflect the terms of the Business Combination. In May 2021, the Company’s board of directors granted stock options under the 2018 Plan to purchase an aggregate of approximately 2,191 shares of common stock at an exercise price of $1.10 per share. The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. The following weighted-average assumptions were used as inputs to the pricing model for options granted during the nine months ended September 30, 2021 (there were no grants made in 2022): Risk-free interest rate 1.0 % Expected term in years 5.90 Expected volatility 61.2 % Expected dividend yield 0.0 % Stock option activity under the 2018 Plan for the quarterly periods ended September 30, 2022 was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at January 1, 2022 3,851 $ 1.77 Exercised (114) 1.12 Forfeited or expired (56) 1.08 Outstanding at March 31, 2022 3,681 $ 1.78 $ 23,918 8.62 Exercised (29) $ 1.05 Forfeited or expired (3) $ 2.30 Outstanding at June 30, 2022 3,649 $ 1.78 $ 11,307 8.35 Exercised (5) 0.79 Forfeited or expired (110) 7.75 Outstanding at September 30, 2022 1 3,534 $ 1.60 $ 84 8.29 Vested and exercisable 1,849 $ 1.18 $ 82 7.80 1 Includes 2,478, 0, and 1,056 of awards accounted for as service-based, performance-based, and market-based options, respectively, that are vested, that the Company currently deems probable of vesting, or in the case of market-based options, that the Company is expensing so long as the respective service conditions are met. The performance options vest only if gross revenue equals or exceeds certain thresholds for the years ending December 31, 2022 and 2023, while the market-based options will vest only if the price of the Company's common stock reaches a $1,000,000 market capitalization target for any 20 days during a 30-day period on or before the fourth anniversary of the closing of the Merger. As of September 30, 2022, there was: (i) $1,219 of unrecognized compensation cost related to service-based awards, which is expected to be recognized over a weighted-average service period of approximately 2.13 years; and (ii) $1,687 of unrecognized compensation cost related to market-based awards, which is expected to be recognized over a weighted-average service period of approximately 1.55 years. The following tables presents the classification of stock-based compensation expense under the 2018 Plan and the 2021 Plan: Three Months Ended September 30, 2022 Nine Months Ended September 30, 2022 2021 2022 2021 Sales and marketing $ 77 $ 15 $ 137 $ 65 Product development 86 14 123 126 General and administrative 608 179 2,899 538 $ 771 $ 208 $ 3,159 $ 729 Earn Out Plan The Earn Out Plan became effective immediately upon closing of the Business Combination. Pursuant to the Earn Out Plan, approximately 571 shares of common stock have been reserved for issuance to employees and certain other eligible parties in the form of restricted stock units (“RSUs”). These RSUs will vest if the Company achieves certain thresholds prior to the third anniversary of the Merger. No RSUs have been awarded under the Earn Out Plan as of September 30, 2022. Option Modification Concurrent with the closing of the Business Combination, the vesting provisions of certain stock options previously granted in 2021 to our Chief Executive Officer to purchase 2,917 shares of common stock were modified, and a corresponding charge of $1,366 was recorded for the three months ended March 31, 2022 to general and administrative expenses and additional paid-in capital. The original award included the following vesting provisions: • Liquidity Event Option : A stock option to purchase 1,458 shares of common stock will vest upon the earlier of (a) the closing of the Initial Public Offering of the Company's common stock or (b) a change in control, provided the recipient remains in continuous service. • Milestone Option : A stock option to purchase 1,458 shares of common stock will vest one-third each upon the achievement of the three annual revenue targets of $75,000, $150,000 and $300,000, provided the recipient remains in continuous service. The modified vesting provisions are as follows: • Liquidity Event Option : A stock option to purchase 1,458 shares of common stock will vest as follows, provided the recipient remains in continuous service: 50% upon the closing of the Business Combination and 50% upon the earlier of (i) the Company's achievement of a $1,000,000 market capitalization for any 20 during a 30-day period on or before the fourth anniversary of the closing of the Business Combination (the "Market Cap Milestone") or (ii) a change in control. • Milestone Option : A stock option to purchase 1,458 shares of common stock will vest upon the achievement of the following milestones, provided that the recipient remains in continuous service: ◦ First Milestone : 50% of the total number of shares subject to the stock option will vest if the Company's gross revenue for the year ending December 31, 2022 equals or exceeds $65,000. A pro rata amount vests in the event that the Company's gross revenue equals or exceeds 90% of the revenue target. ◦ Second Milestone : 50% of the total number of shares subject to the stock option will vest if the Company's gross revenue for the year ending December 31, 2023 equals or exceeds $101,000. A pro rata amount vests in the event that the Company's gross revenue equals or exceeds 90% of the revenue target. ◦ In the event the Second Milestone is achieved, any unvested portion of the stock option subject to the First Milestone will fully vest. ◦ In the event the Market Cap Milestone is achieved, any unvested portion of the Milestone Option will fully vest. ◦ The date of vesting for the Milestone Option will be the earlier of (i) the date following the Company's filing with the SEC of its Form 10-K for the applicable fiscal year in which the applicable revenue target was attained or, (ii) the date of the Market Cap Milestone is achieved. ◦ All shares subject to the Milestone Option will vest immediately upon a change in control. ◦ The Milestone Option will remain outstanding unless and until the last possible time that the Second Milestone can be achieved, the Market Cap Milestone can be achieved, or a change in control may occur during the term of the Milestone Option award, subject to the recipient's continued service.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions One of Leafly's significant investors, Brendan Kennedy, is a member of the board of directors of Tilray, Inc., which is the parent company of High Park Holdings Ltd., a customer of Leafly, and has therefore been identified as a related party. During the three months ended September 30, 2022 and 2021, the Company recorded approximately $— and $11, respectively, of revenue earned from contracts with this customer, and during the nine months ended September 30, 2022 and 2021, the Company recorded approximately $— and $125, respectively, of revenue earned from contracts with this customer. In June 2021, Mr. Kennedy, purchased a convertible promissory note totaling $1,000. The note was issued as part of the existing series of 2021 Notes (see Note 11) and was subject to the same interest rate, maturity, and conversion terms. This note converted to shares of Leafly common stock upon closing of the Business Combination in February 2022, along with the other 2021 Notes.

Defined Contribution Plan

Defined Contribution Plan	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Defined Contribution Plan	Defined Contribution PlanThe Company recognized expense from matching contributions to the Company-sponsored defined contribution retirement (401k) plan of $225 and $159 for the three months ended September 30, 2022 and 2021, respectively, and $684 and $528 for the nine months ended September 30, 2022 and 2021, respectively.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic and diluted net income (loss) per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Under the two-class method, basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Shares repurchased and held in treasury by the Company are removed from the weighted-average number of shares of common stock outstanding as of the date of repurchase. The Company considers its preferred stock to be participating securities. As of September 30, 2022, the Company had 5,429 outstanding shares of common stock that are in escrow and subject to earn-out conditions and thus forfeiture, which do not meet the criteria for participating securities (see Note 12 — Stockholders' Equity for additional information). Net income (loss) is attributed to common stockholders and participating securities based on their participation rights. Net income (loss) is not attributed to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in any losses. Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of non-participating shares of common stock that are subject to forfeiture, stock options, preferred stock, convertible notes, and other securities outstanding. Certain securities are antidilutive and as such, are excluded from the calculation of diluted earnings per share and disclosed separately. Because of the nature of the calculation, particular securities may be dilutive in some periods and anti-dilutive in other periods. The Class 1, 2, and 3 common shares presented below have been retroactively restated for all periods using the conversion ratio in connection with the Business Combination. The following table presents the computation of basic and diluted net income (loss) per share attributable to common stockholders, as a group, for the periods presented: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss) (A) $ 15,454 $ (4,454) $ 10,837 $ (6,880) Income impact of FPAs (3,939) — (346) — Income impact of convertible promissory notes 600 — — — Total undistributed income (loss) (B) 12,115 (4,454) 10,491 (6,880) Weighted average shares outstanding (C) 35,580 24,923 35,260 24,832 Dilutive effect of FPAs 3,547 — 1,140 — Dilutive effect of convertible promissory notes 2,477 — — — Dilutive effect of stock-based awards 1,611 — 2,304 — Common stock and common stock equivalents (D) 43,215 24,923 38,704 24,832 Net income (loss) per share: Basic (A/C) $ 0.43 $ (0.18) $ 0.31 $ (0.28) Diluted (B/D) $ 0.28 $ (0.18) $ 0.27 $ (0.28) During 2022, the Class 1, 2, and 3 shares were outstanding from January 1, 2022 through February 3, 2022, while only one class of common stock was outstanding beginning February 4, 2022. During 2021, only the Class 1, 2, and 3 shares were outstanding. Following are the calculations of basic and diluted net income (loss) per share for each class of common stock (refer to the tables above for the impact of common stock equivalents on common shares for the three and nine months ended September 30, 2022): Three Months Ended Three Months Ended Common Class 1 Class 2 Class 3 Net income (loss) $ 15,454 $ (1,676) $ (2,458) $ (320) Weighted average shares outstanding 35,580 9,379 13,755 1,789 Common stock and common stock equivalents 43,215 9,379 13,755 1,789 Basic net income (loss) per share $ 0.43 $ (0.18) $ (0.18) $ (0.18) Diluted net income (loss) per share $ 0.28 $ (0.18) $ (0.18) $ (0.18) Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Common Class 1 Class 2 Class 3 Net loss $ 10,837 $ (2,598) $ (3,811) $ (471) Weighted average shares outstanding 35,260 9,379 13,755 1,698 Common stock and common stock equivalents 38,704 9,379 13,755 1,698 Basic net income (loss) per share $ 0.31 $ (0.28) $ (0.28) $ (0.28) Diluted net income (loss) per share $ 0.27 $ (0.28) $ (0.28) $ (0.28) The following shares of common stock subject to certain instruments were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented as their effect would have been antidilutive (with figures recast using the conversion ratio for the Business Combination, as applicable): Three Months Ended Nine Months Ended September 30, 2022 2021 2022 2021 Shares subject to warrants 10,451 — 10,451 — Shares subject to convertible promissory notes — 12,240 2,428 12,240 Preferred stock — 6,141 — 6,141 Escrow Shares 1,625 — 1,625 — Shares subject to outstanding common stock options and RSUs 1,056 3,785 1,056 3,785 Shares subject to stockholder earn-out rights 5,429 — 5,429 — $ 18,561 $ 22,166 $ 20,989 $ 22,166 See Note 11 for additional information regarding convertible promissory notes, Note 12 for additional information regarding stockholder earn-out rights, preferred stock, and Escrow Shares, Note 13 for additional information regarding warrants, and Note 14 for additional information regarding stock options and RSUs.

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting Segment revenue and gross profit were as follows during the periods presented: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Revenue: Retail $ 9,042 $ 8,606 $ 27,286 $ 24,572 Brands 2,739 2,290 7,965 6,387 Total revenue $ 11,781 $ 10,896 $ 35,251 $ 30,959 Gross profit: Retail 7,979 7,744 24,193 22,339 Brands 2,287 1,891 6,647 5,056 Total gross profit $ 10,266 $ 9,635 $ 30,840 $ 27,395 Assets are not allocated to segments for internal reporting presentations, nor are depreciation and amortization. Geographic Areas The Company’s operations are primarily in the U.S. and to a lesser extent, in certain other countries. Refer to Note 9 for revenue classified by major geographic area.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company follows the guidance in ASC 820, "Fair Value Measurement," for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 : Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 : Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3 : Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company’s financial instruments include cash equivalents, restricted cash, accounts receivable from customers, accounts payable and accrued liabilities, all of which are typically short-term in nature. The Company believes that the carrying amounts of these financial instruments reasonably approximate their fair values due to their short-term nature. The following table presents information about the Company’s derivative liabilities that are measured at fair value on a recurring basis beginning February 4, 2022 (the date of closing of the Business Combination) when the derivative liabilities were assumed, and discloses the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level Fair Value at September 30, 2022 Fair Value at June 30, 2022 Fair Value at February 4, 2022 Gain (Loss) Three Months Ended September 30, 2022 1 Gain (Loss) Nine Months Ended September 30, 2022 1 Private Warrants derivative liability 3 $ 662 $ 3,693 $ 3,916 $ 3,031 $ 3,254 Forward share purchase agreements derivative liability 2 3 — 17,763 14,170 3,939 346 Escrow Shares derivative liability 3 47 3,481 6,868 3,434 6,821 Stockholder earn-out rights derivative liability 3 288 12,147 26,131 11,859 25,843 Total $ 997 $ 37,084 $ 51,085 22,264 $ 36,264 1 Totals may not foot due to rounding. 2 The forward share purchase agreements were settled effective August 1, 2022, at which time the fair value was $13,824 based on cash settlement. Assumptions used to determine the fair values are presented in the following sections: Private Warrants Derivative Liability The Private Warrants were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 Exercise price $ 11.50 $ 11.50 $ 11.50 Stock price $ 0.68 $ 4.50 $ 6.53 Volatility 98.0% 51.6% 34.3% Term (in years) 4.34 4.59 5.00 Risk-free rate 4.1% 3.0% 1.8% Dividend yield 0.0% 0.0% 0.0% The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies and the volatility of the Public Warrants. The term input represents the maximum contractual term, though the Private Warrants may be exercised earlier. The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Forward Share Purchase Agreements Derivative Liability The FPAs were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 Exercise price - one agreement N/A $ 10.31 $ 10.16 Exercise price - three agreements N/A $ 10.16 $ 10.01 Stock price N/A $ 4.50 $ 6.53 Volatility N/A 70.4% 63.9% Term (in years) N/A 0.09 0.24 Risk-free rate N/A 1.3% 0.2% Dividend yield N/A 0.0% 0.0% The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies. The term input represents the maximum contractual term, though the shares underlying the FPAs may be sold by the holders into the open market earlier, which in some cases they have been (see Note 13). The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Escrow Shares Derivative Liability The Escrow Shares derivative liability was calculated using a binomial lattice model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 First stock price trigger $ 13.50 $ 13.50 $ 13.50 Second stock price trigger $ 15.50 $ 15.50 $ 15.50 Stock price $ 0.68 $ 4.50 $ 6.53 Volatility 79.0% 68.0% 64.0% Term (in years) 2.34 2.59 3.00 Risk-free rate 4.2% 3.0% 1.6% Dividend yield 0.0% 0.0% 0.0% The volatility input was calculated using a weighted average of historical volatilities from select benchmark companies. The term input represents the maximum contractual term, though the shares may be released from escrow earlier. The interest rate input is the U.S. Treasury constant maturity rate for the instrument that most closely matches the term input. Stockholder Earn-Out Rights Derivative Liability The stockholder earn-out rights were valued using a binomial lattice model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 First stock price trigger $ 13.50 $ 13.50 $ 13.50 Second stock price trigger $ 15.50 $ 15.50 $ 15.50 First revenue trigger $ 65,000 $ 65,000 $ 65,000 Second revenue trigger $ 101,000 $ 101,000 $ 101,000 Stock price $ 0.68 $ 4.50 $ 6.53 2022 Revenue assumption $ 47,500 $ 49,500 $ 55,500 Volatility 79.0% 68.0% 64.0% Term (in years) 2.34 2.59 3.00 Risk-free rate 4.2% 3.0% 1.6% Dividend yield 0.0% 0.0% 0.0%

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Issuance of Restricted Stock Units On October 6, 2022, the Company awarded 512,203 restricted stock units to employees and members of its board of directors, and 819,721 performance stock units to employees. Restructuring Plan On October 18, 2022, the Company committed to a restructuring plan (the “Restructuring Plan”), which is intended to support its strategic plan in an effort to improve operating performance and ensure that the Company is appropriately structured and resourced to deliver sustainable value to its customers and shareholders. Key activities under the Restructuring Plan include a focus on efficiency and cost-saving efforts, which includes decreasing, through attrition and layoffs, total headcount by approximately 56 employees upon the completion of the Restructuring Plan. These activities are expected to be substantially completed by the end of 2022. The Company currently estimates it will incur cash pre-tax restructuring charges of approximately $500, primarily in the fourth quarter of 2022, as a result of the Restructuring Plan, comprised primarily of one-time severance and other employee-related termination benefits. Estimated amounts are subject to change until finalized. Nasdaq Notifications of Noncompliance On October 28, 2022, the Company received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) providing notification that the Company no longer complies with the $50 million in market value of listed securities standard for continued listing on the Nasdaq Global Market under Nasdaq’s Listing Rule 5450(b)(2)(A) and that the Company also does not comply with either of the two alternative standards of Listing Rule 5450(b), the equity standard and the total assets and total revenue standard. On November 2, 2022, Leafly received another letter from the Nasdaq staff providing notification that, for the previous 30 consecutive business days, the bid price for Leafly’s common stock had closed below the $1.00 per share minimum bid price requirement for continued listing under Nasdaq Listing Rule 5450(a)(1). The notices have no immediate effect on the listing of the Company’s common stock or warrants, and its common stock and warrants will continue to trade on The Nasdaq Global Market under the symbol “LFLY” and “LFLYW,” respectively. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180 calendar days, or until April 26, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the market value of the Company’s common stock must be $50 million or more for a minimum of 10 consecutive business days at any time before April 26, 2023 and we must otherwise satisfy the Nasdaq Global Market’s requirements for continued listing. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until May 1, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before May 1, 2023 and we must otherwise satisfy the Nasdaq Global Market’s requirements for continued listing The Company's failure to regain compliance during this period could result in delisting. If the Company is not able to achieve compliance with an applicable listing standard under Listing Rule 5450(b) prior to April 26, 2023, the Company may be eligible to transfer the listing for its common stock to the Nasdaq Capital Market. To qualify, the Company would be required to meet the continued listing requirements for the Nasdaq Capital Market. If the Company does not regain compliance with the minimum bid price requirement by May 1, 2023, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company would need to transfer the listing of its common stock to the Nasdaq Capital Market, provided that it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq would notify the Company that its securities would be subject to delisting. In the event of such a notification, the Company may appeal the Staff’s determination to delist its securities, but there can be no assurance the Staff would grant the Company’s request for continued listing.

Basis of Presentation and Sig_2

Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	The interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ( “ GAAP ” ) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting and should be read in conjunction with the Company's audited consolidated financial statements for the years
Use of Estimates	These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions.
Consolidation	All intercompany balances and transactions have been eliminated upon consolidation.
Reclassifications	Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported net income (loss).
Capitalized Software	The Company capitalizes certain costs related to acquisition and development of software for internal use, including internal labor costs incurred during development. The Company begins to capitalize these costs when planning and design efforts are successfully completed and development is ready to commence. Costs incurred during planning and design, together with costs incurred for training and maintenance, are expensed as incurred and recorded in product development expense. The Company places capitalized software assets into service and commences amortization when the asset is substantially complete and ready for its intended use. Once placed into service, the Company capitalizes qualifying costs of specified upgrades or enhancements to the assets when the upgrade or enhancement will result in new or additional functionality.The Company’s estimated useful life for capitalized software is 3 years, and amortization is calculated using the straight-line method. The Company considers the useful life of capitalized software to be a significant estimate.
Transaction Costs	The Company incurred significant costs direct and incremental to the Business Combination and therefore to the recapitalization of the Company. We deferred such costs incurred in 2021. In 2022, upon closing of the Business Combination, total direct transaction costs were allocated between equity and liability instruments measured at fair value on a recurring basis that were newly issued in the recapitalization. Amounts allocated to equity were recorded to additional paid-in capital, while amounts allocated to the specified liabilities were recorded as other expense.
Recently Adopted Accounting Standards and Accounting Pronouncements Issued But Not Yet Adopted	Recently Adopted Accounting Standards None. Accounting Pronouncements Issued But Not Yet Adopted

Description of the Business a_2

Description of the Business and Merger Transaction (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Merger	The following table provides a summary of the significant sources and uses of cash related to the closing of the Business Combination on February 4, 2022 and the cash received from escrow through September 30, 2022: Amount in Merida's trust account ("the Trust") at closing $ 90,824 Total payment to Merida public redeeming stockholders 49,466 Amount available after paying Merida redeeming stockholders 41,358 Cash to escrow for Forward Share Purchase Agreements (see Note 13) 39,032 Remaining balance 2,326 Merida expenses paid from the Trust at closing 1,744 Net cash from the Trust to Leafly at closing 582 Cash received from escrow February 4, 2022 - September 30, 2022 8,089 Net cash from the Trust to Leafly as of September 30, 2022 $ 8,671 The following table provides a reconciliation of the common shares related to the Merger transaction: Merida public stockholders 4,160 Merida initial stockholders (including Sponsor and EarlyBirdCapital) 1,667 Holders of 2022 Notes (see Note 11) 38 Shares held by Sponsor in escrow that are subject to earn-out conditions (see Note 12) 1,625 Total Merida 7,490 Legacy Leafly existing securityholders 35,434 Total shares outstanding as of February 4, 2022 42,924

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	9 Months Ended
	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash consisted of the following: September 30, December 31, Cash and cash equivalents $ 27,829 $ 28,565 Restricted cash 607 130 $ 28,436 $ 28,695
Schedule of Restricted Cash	Cash, cash equivalents, and restricted cash consisted of the following: September 30, December 31, Cash and cash equivalents $ 27,829 $ 28,565 Restricted cash 607 130 $ 28,436 $ 28,695

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following: September 30, December 31, Prepaid insurance $ 2,065 $ 57 Other prepaid expenses 1,441 1,134 Other current assets 63 156 $ 3,569 $ 1,347

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Schedule of Allowance for Doubtful Accounts	The following table presents the allowance for doubtful accounts and the changes therein: Three Months Ended Nine Months Ended September 30, 2022 2021 2022 2021 Balance, beginning of period $ 1,469 $ 1,142 $ 1,848 $ 1,131 Add: provision for doubtful accounts, net of recoveries 383 529 1,023 841 Less: write-offs (894) (93) (1,913) (394) Balance, end of period $ 958 $ 1,578 $ 958 $ 1,578

Property, Equipment and Softw_2

Property, Equipment and Software, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property, equipment, and software consisted of the following: September 30, December 31, Furniture and equipment $ 902 $ 1,049 Leasehold improvements — 2 Internal-use software 2,081 — 2,983 1,051 Less: accumulated depreciation and amortization (770) (738) $ 2,213 $ 313

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses consist of the following: September 30, December 31, Accrued bonuses $ 537 $ 3,668 Other employee-related liabilities 2,547 2,131 Accrued interest 400 1,313 Other accrued expenses 1 1,592 1,213 $ 5,076 $ 8,325 1 There are no individual items within this balance that exceed 10% of the total of the table.

Revenue and Contract Balances (

Revenue and Contract Balances (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the Company's revenue by service type: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Advertising $ 11,731 $ 10,840 $ 34,959 $ 30,813 Other services 50 56 292 146 $ 11,781 $ 10,896 $ 35,251 $ 30,959 The following table presents the Company's revenue by geographic region: Three Months Ended Nine Months Ended 2022 2021 2022 2021 United States 1 $ 11,140 $ 9,757 $ 32,787 $ 27,644 All other countries 1 641 1,139 2,464 3,315 $ 11,781 $ 10,896 $ 35,251 $ 30,959 1 Calculated based on customer sold to address for the periods presented. Using the prior calculation based on billing entity address, revenue for the United States and All other countries would have been $11,335 and $446 for the three months ended September 30, 2022, $10,041 and $855 for the three months ended September 30, 2021, $33,491 and $1,760 for the nine months ended September 30, 2022, and $28,204 and $2,755 for the nine months ended September 30, 2021, respectively. The following tables presents the Company's revenue by state: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Arizona 19 % 16 % 18 % 16 % California 13 % 11 % 11 % 10 % Oregon 10 % 11 % 10 % 12 % The following table presents the Company's revenue by timing of recognition: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Over time Retail 1 $ 9,042 $ 8,606 $ 27,286 $ 24,572 Brands 2 1,759 1,581 5,067 4,591 $ 10,801 $ 10,187 $ 32,353 $ 29,163 Point in time Brands 3 980 709 2,898 1,796 $ 11,781 $ 10,896 $ 35,251 $ 30,959 1 Revenues from subscription services and display ads. 2 Revenues from brand profile subscriptions and digital media (including display ads and audience extension). 3 Revenues from branded content and channel advertising (including direct to consumer email).
Schedule of Deferred Revenue	The following table presents the Company's deferred revenue accounts and changes in the deferred revenue accounts Three Months Ended Nine Months Ended 2022 2021 2022 2021 Balance, beginning of period $ 2,467 $ 2,079 $ 1,975 $ 1,585 Add: net increase in current period contract liabilities 1,630 1,947 1,976 2,112 Less: revenue recognized from beginning balance (2,045) (1,847) (1,899) (1,518) Balance, end of period $ 2,052 $ 2,179 $ 2,052 $ 2,179

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Weighted-Average Assumptions Used in Option Pricing Model	The fair value of each stock option award to employees is estimated on the date of grant using the Black-Scholes option pricing model. The following weighted-average assumptions were used as inputs to the pricing model for options granted during the three and nine months ended September 30, 2022: Risk-free interest rate 4.1 % Expected term in years 4.06 Expected volatility 74.6 % Expected dividend yield 0.0 % Risk-free interest rate 1.0 % Expected term in years 5.90 Expected volatility 61.2 % Expected dividend yield 0.0 %
Schedule of Stock Option Activity	Stock option activity under the 2021 Plan for the three months ended September 30, 2022 (there were no stock options granted previously under this plan) was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at June 30, 2022 — $ — $ — — Granted 101 1.98 Exercised — — Forfeited or expired — — Outstanding at September 30, 2022 101 $ 1.98 $ — 9.89 Vested and exercisable — $ — $ — — Stock option activity under the 2018 Plan for the quarterly periods ended September 30, 2022 was as follows: Number of Weighted Average Aggregate Weighted Average Remaining Contractual Term (in years) Outstanding at January 1, 2022 3,851 $ 1.77 Exercised (114) 1.12 Forfeited or expired (56) 1.08 Outstanding at March 31, 2022 3,681 $ 1.78 $ 23,918 8.62 Exercised (29) $ 1.05 Forfeited or expired (3) $ 2.30 Outstanding at June 30, 2022 3,649 $ 1.78 $ 11,307 8.35 Exercised (5) 0.79 Forfeited or expired (110) 7.75 Outstanding at September 30, 2022 1 3,534 $ 1.60 $ 84 8.29 Vested and exercisable 1,849 $ 1.18 $ 82 7.80
Schedule of Restricted Stock Unit Activity	Restricted stock unit activity under the 2021 Plan for the three months ended September 30, 2022 (there were no restricted stock units granted previously under this plan) was as follows: Number of Weighted Average Total Fair Value Unvested at June 30, 2022 — $ — Granted 1,228 1.98 $ 2,432 Vested (173) 1.98 $ 325 Forfeited (65) 1.98 Unvested at September 30, 2022 990 $ 1.98
Schedule of Stock-Based Compensation Expense	The following tables presents the classification of stock-based compensation expense under the 2018 Plan and the 2021 Plan: Three Months Ended September 30, 2022 Nine Months Ended September 30, 2022 2021 2022 2021 Sales and marketing $ 77 $ 15 $ 137 $ 65 Product development 86 14 123 126 General and administrative 608 179 2,899 538 $ 771 $ 208 $ 3,159 $ 729

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Computation Basic and Diluted Net Income (Loss) Per Share	The following table presents the computation of basic and diluted net income (loss) per share attributable to common stockholders, as a group, for the periods presented: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss) (A) $ 15,454 $ (4,454) $ 10,837 $ (6,880) Income impact of FPAs (3,939) — (346) — Income impact of convertible promissory notes 600 — — — Total undistributed income (loss) (B) 12,115 (4,454) 10,491 (6,880) Weighted average shares outstanding (C) 35,580 24,923 35,260 24,832 Dilutive effect of FPAs 3,547 — 1,140 — Dilutive effect of convertible promissory notes 2,477 — — — Dilutive effect of stock-based awards 1,611 — 2,304 — Common stock and common stock equivalents (D) 43,215 24,923 38,704 24,832 Net income (loss) per share: Basic (A/C) $ 0.43 $ (0.18) $ 0.31 $ (0.28) Diluted (B/D) $ 0.28 $ (0.18) $ 0.27 $ (0.28) Three Months Ended Three Months Ended Common Class 1 Class 2 Class 3 Net income (loss) $ 15,454 $ (1,676) $ (2,458) $ (320) Weighted average shares outstanding 35,580 9,379 13,755 1,789 Common stock and common stock equivalents 43,215 9,379 13,755 1,789 Basic net income (loss) per share $ 0.43 $ (0.18) $ (0.18) $ (0.18) Diluted net income (loss) per share $ 0.28 $ (0.18) $ (0.18) $ (0.18) Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Common Class 1 Class 2 Class 3 Net loss $ 10,837 $ (2,598) $ (3,811) $ (471) Weighted average shares outstanding 35,260 9,379 13,755 1,698 Common stock and common stock equivalents 38,704 9,379 13,755 1,698 Basic net income (loss) per share $ 0.31 $ (0.28) $ (0.28) $ (0.28) Diluted net income (loss) per share $ 0.27 $ (0.28) $ (0.28) $ (0.28)
Schedule of Antidilutive Shares	The following shares of common stock subject to certain instruments were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented as their effect would have been antidilutive (with figures recast using the conversion ratio for the Business Combination, as applicable): Three Months Ended Nine Months Ended September 30, 2022 2021 2022 2021 Shares subject to warrants 10,451 — 10,451 — Shares subject to convertible promissory notes — 12,240 2,428 12,240 Preferred stock — 6,141 — 6,141 Escrow Shares 1,625 — 1,625 — Shares subject to outstanding common stock options and RSUs 1,056 3,785 1,056 3,785 Shares subject to stockholder earn-out rights 5,429 — 5,429 — $ 18,561 $ 22,166 $ 20,989 $ 22,166

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of Segment Revenue and Gross Profit	Segment revenue and gross profit were as follows during the periods presented: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Revenue: Retail $ 9,042 $ 8,606 $ 27,286 $ 24,572 Brands 2,739 2,290 7,965 6,387 Total revenue $ 11,781 $ 10,896 $ 35,251 $ 30,959 Gross profit: Retail 7,979 7,744 24,193 22,339 Brands 2,287 1,891 6,647 5,056 Total gross profit $ 10,266 $ 9,635 $ 30,840 $ 27,395

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s derivative liabilities that are measured at fair value on a recurring basis beginning February 4, 2022 (the date of closing of the Business Combination) when the derivative liabilities were assumed, and discloses the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level Fair Value at September 30, 2022 Fair Value at June 30, 2022 Fair Value at February 4, 2022 Gain (Loss) Three Months Ended September 30, 2022 1 Gain (Loss) Nine Months Ended September 30, 2022 1 Private Warrants derivative liability 3 $ 662 $ 3,693 $ 3,916 $ 3,031 $ 3,254 Forward share purchase agreements derivative liability 2 3 — 17,763 14,170 3,939 346 Escrow Shares derivative liability 3 47 3,481 6,868 3,434 6,821 Stockholder earn-out rights derivative liability 3 288 12,147 26,131 11,859 25,843 Total $ 997 $ 37,084 $ 51,085 22,264 $ 36,264 1 Totals may not foot due to rounding. 2 The forward share purchase agreements were settled effective August 1, 2022, at which time the fair value was $13,824 based on cash settlement.
Schedule of Valuation Assumptions	The Private Warrants were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 Exercise price $ 11.50 $ 11.50 $ 11.50 Stock price $ 0.68 $ 4.50 $ 6.53 Volatility 98.0% 51.6% 34.3% Term (in years) 4.34 4.59 5.00 Risk-free rate 4.1% 3.0% 1.8% Dividend yield 0.0% 0.0% 0.0% The FPAs were valued using a Black-Scholes model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 Exercise price - one agreement N/A $ 10.31 $ 10.16 Exercise price - three agreements N/A $ 10.16 $ 10.01 Stock price N/A $ 4.50 $ 6.53 Volatility N/A 70.4% 63.9% Term (in years) N/A 0.09 0.24 Risk-free rate N/A 1.3% 0.2% Dividend yield N/A 0.0% 0.0% The Escrow Shares derivative liability was calculated using a binomial lattice model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 First stock price trigger $ 13.50 $ 13.50 $ 13.50 Second stock price trigger $ 15.50 $ 15.50 $ 15.50 Stock price $ 0.68 $ 4.50 $ 6.53 Volatility 79.0% 68.0% 64.0% Term (in years) 2.34 2.59 3.00 Risk-free rate 4.2% 3.0% 1.6% Dividend yield 0.0% 0.0% 0.0% The stockholder earn-out rights were valued using a binomial lattice model and the following Level 3 inputs: September 30, 2022 June 30, 2022 February 4, 2022 First stock price trigger $ 13.50 $ 13.50 $ 13.50 Second stock price trigger $ 15.50 $ 15.50 $ 15.50 First revenue trigger $ 65,000 $ 65,000 $ 65,000 Second revenue trigger $ 101,000 $ 101,000 $ 101,000 Stock price $ 0.68 $ 4.50 $ 6.53 2022 Revenue assumption $ 47,500 $ 49,500 $ 55,500 Volatility 79.0% 68.0% 64.0% Term (in years) 2.34 2.59 3.00 Risk-free rate 4.2% 3.0% 1.6% Dividend yield 0.0% 0.0% 0.0%

Description of the Business a_3

Description of the Business and Merger Transaction - Significant Sources and Uses of Cash (Details) $ in Thousands		8 Months Ended	9 Months Ended
	Feb. 04, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Schedule Of Reverse Recapitalization [Line Items]
Merida expenses paid from the Trust at closing			$ 10,761	$ 0
Net cash from the Trust to Leafly at closing	$ 582	$ 8,671
Cash released from escrow		$ 8,089
Convertible Senior Notes | 2021 Notes
Schedule Of Reverse Recapitalization [Line Items]
Conversion ratio	0.3283
Merida
Schedule Of Reverse Recapitalization [Line Items]
Amount in Merida's trust account ("the Trust") at closing	$ 90,824
Total payment to Merida public redeeming stockholders	49,466
Amount available after paying Merida redeeming stockholders	41,358
Cash to escrow for Forward Share Purchase Agreements (see Note 13)	39,032
Remaining balance	2,326
Merida expenses paid from the Trust at closing	$ 1,744

Description of the Business a_4

Description of the Business and Merger Transaction - Reconciliation of Common Shares (Details) - shares shares in Thousands	Feb. 04, 2022	Feb. 03, 2022	Dec. 31, 2021
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)	42,924		25,086
Leafly existing securityholders (in shares)	35,434
Merida
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)		7,490
Merida | Public stockholders
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)		4,160
Merida | Initial stockholders
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)		1,667
Merida | Noteholders
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)		38
Merida | Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Common stock, outstanding (in shares)		1,625

Basis of Presentation and Sig_3

Basis of Presentation and Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2022
Internal-use software
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash - Schedule (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 27,829	$ 28,565
Restricted cash	607	130
Cash, cash equivalents, and restricted cash	$ 28,436	$ 28,695	$ 33,246	$ 4,934

Cash, Cash Equivalents, and R_4

Cash, Cash Equivalents, and Restricted Cash - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Feb. 04, 2022	Dec. 31, 2021
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 607		$ 130
Purchase of treasury stock	0
Escrow deposit
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 360	$ 39,032

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid insurance	$ 2,065	$ 57
Other prepaid expenses	1,441	1,134
Other current assets	63	156
Prepaid expenses and other current assets	$ 3,569	$ 1,347

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, beginning of period	$ 1,469	$ 1,142	$ 1,848	$ 1,131
Add: provision for doubtful accounts, net of recoveries	383	529	1,023	841
Less: write-offs	(894)	(93)	(1,913)	(394)
Balance, end of period	$ 958	$ 1,578	$ 958	$ 1,578

Property, Equipment and Softw_3

Property, Equipment and Software, Net - Schedule (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,983	$ 1,051
Less: accumulated depreciation and amortization	(770)	(738)
Property, equipment, and software, net	2,213	313
Furniture and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	902	1,049
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	0	2
Internal-use software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,081	$ 0

Property, Equipment and Softw_4

Property, Equipment and Software, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 38	$ 57	$ 135	$ 195
Amortization of internal-use software	$ 90	$ 0	$ 141	$ 0

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued bonuses	$ 537	$ 3,668
Other employee-related liabilities	2,547	2,131
Accrued interest	400	1,313
Other accrued expenses	1,592	1,213
Accrued expenses and other current liabilities	$ 5,076	$ 8,325
CEO
Accrued Expenses [Line Items]
Bonus, percentage of base salary	50%
Other named executive officers
Accrued Expenses [Line Items]
Bonus, percentage of base salary	40%

Revenue and Contract Balances -

Revenue and Contract Balances - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 11,781	$ 10,896	$ 35,251	$ 30,959
Retail
Disaggregation of Revenue [Line Items]
Revenue	9,042	8,606	27,286	24,572
Brands
Disaggregation of Revenue [Line Items]
Revenue	2,739	2,290	7,965	6,387
Over time
Disaggregation of Revenue [Line Items]
Revenue	10,801	10,187	32,353	29,163
Over time | Retail
Disaggregation of Revenue [Line Items]
Revenue	9,042	8,606	27,286	24,572
Over time | Brands
Disaggregation of Revenue [Line Items]
Revenue	1,759	1,581	5,067	4,591
Point in time | Brands
Disaggregation of Revenue [Line Items]
Revenue	980	709	2,898	1,796
United States
Disaggregation of Revenue [Line Items]
Revenue	11,140	9,757	32,787	27,644
United States | Reclassification due to change in calculation method
Disaggregation of Revenue [Line Items]
Revenue	11,335	10,041	33,491	28,204
All other countries
Disaggregation of Revenue [Line Items]
Revenue	641	1,139	2,464	3,315
All other countries | Reclassification due to change in calculation method
Disaggregation of Revenue [Line Items]
Revenue	$ 446	$ 855	$ 1,760	$ 2,755
Arizona | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	19%	16%	18%	16%
California | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	13%	11%	11%	10%
Oregon | Revenue | Geographic concentration risk
Disaggregation of Revenue [Line Items]
Concentration risk percentage	10%	11%	10%	12%
Advertising
Disaggregation of Revenue [Line Items]
Revenue	$ 11,731	$ 10,840	$ 34,959	$ 30,813
Other services
Disaggregation of Revenue [Line Items]
Revenue	$ 50	$ 56	$ 292	$ 146

Revenue and Contract Balances_2

Revenue and Contract Balances - Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Change in Contract with Customer, Liability [Roll Forward]
Balance, beginning of period	$ 2,467	$ 2,079	$ 1,975	$ 1,585
Add: net increase in current period contract liabilities	1,630	1,947	1,976	2,112
Less: revenue recognized from beginning balance	(2,045)	(1,847)	(1,899)	(1,518)
Balance, end of period	$ 2,052	$ 2,179	$ 2,052	$ 2,179

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Effective tax rate	0%	0%	0%	0%
Unrecognized tax benefits	$ 0		$ 0		$ 0
Unrecognized tax benefits, accrued interest and penalties	$ 0		$ 0		0
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward					53,904
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward					35,976
Foreign
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward					$ 4,303

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - Convertible Senior Notes $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended
	Feb. 04, 2022 $ / shares shares	Jan. 31, 2022 USD ($) day $ / shares	Sep. 30, 2022 USD ($)	Aug. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)
2022 Notes
Debt Instrument [Line Items]
Aggregate principal amount		$ 30,000
Debt issuance costs		714
Debt discount		$ 924
Interest rate		8%
Conversion share price (in usd per share) | $ / shares		$ 12.50
Stock price trigger (in usd per share) | $ / shares		$ 18
Threshold trading days | day		20
Threshold consecutive trading days | day		30
Redemption price percentage		100%
Repurchase price percentage		100%
Net carrying amount			$ 28,726
Unamortized issuance costs			1,274
2022 Notes | Level 3
Debt Instrument [Line Items]
Fair value			$ 23,000
2021 Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 7,500	$ 23,970
Interest rate				8%
Conversion share price (in usd per share) | $ / shares	$ 2.63
Conversion of stock (in shares) | shares	4,128
Percent of implied price per share	80%
Conversion ratio	0.3283

Stockholders' Equity (Details)

Stockholders' Equity (Details) $ / shares in Units, $ in Thousands			3 Months Ended	9 Months Ended
	Aug. 01, 2022 USD ($) $ / shares shares	Feb. 04, 2022 USD ($) day $ / shares shares	Sep. 30, 2022 USD ($) class vote $ / shares shares	Sep. 30, 2022 USD ($) class vote $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares shares
Schedule Of Reverse Recapitalization [Line Items]
Common stock, authorized (in shares)			200,000,000	200,000,000		69,361,000
Common stock, par value (in usd per share) | $ / shares			$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, authorized (in shares)			5,000,000	5,000,000		6,578,000
Preferred stock, par value (in usd per share) | $ / shares			$ 0.0001	$ 0.0001		$ 0.0001
Common stock, number of votes per share | vote			1	1
Board of directors, number of classes | class			3	3
Board of directors, term				3 years
Purchase of treasury stock | $			$ 0
Preferred stock, issued (in shares)			0	0		6,140,000
Preferred stock, outstanding (in shares)			0	0		6,140,000
Repurchase of common stock in other accrued expenses | $				$ 360	$ 0
Common
Schedule Of Reverse Recapitalization [Line Items]
Stock repurchased (in shares)	3,081,000
Treasury stock (in usd per share) | $ / shares	$ 10.28
Purchase of treasury stock | $	$ 31,663
Common | Payment using Restricted Cash
Schedule Of Reverse Recapitalization [Line Items]
Purchase of treasury stock | $	31,303
Common | Remaining in Accrued Expenses and Other Current Liabilities
Schedule Of Reverse Recapitalization [Line Items]
Purchase of treasury stock | $	$ 360
Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)		1,625,000	5,429,000	5,429,000
Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)		5,429,000
Derivative instrument, period, one | Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares, percentage of shares released from escrow		50%
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares		$ 13.50
Earn-out shares, earn-out period		2 years
Derivative instrument, period, one | Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)		2,715,000
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares		$ 13.50
Earn-out shares, earn-out period		2 years
Earn-out shares, revenue target | $		$ 65,000
Earn-out shares, threshold trading days | day		20
Earn-out shares, threshold consecutive trading days		30 days
Earn-out shares, pro rate percentage of shares		50%
Earn-out shares, percentage of revenue target		90%
Derivative instrument, period, two | Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares, percentage of shares released from escrow		50%
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares		$ 15.50
Earn-out shares, earn-out period		3 years
Derivative instrument, period, two | Leafly stockholders
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)		2,715,000
Earn-out shares, earn-out period, stock price trigger (in usd per share) | $ / shares		$ 15.50
Earn-out shares, earn-out period		3 years
Earn-out shares, revenue target | $		$ 101,000
Earn-out shares, threshold trading days | day		20
Earn-out shares, threshold consecutive trading days		30 days
Earn-out shares, pro rate percentage of shares		50%
Earn-out shares, percentage of revenue target		90%

Warrants and Forward Purchase_2

Warrants and Forward Purchase Share Agreements - Warrants (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 day $ / shares shares	Dec. 31, 2021 shares
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares) | shares	6,501	6,501
Warrants, exercise price (in usd per share)	$ 11.50
Warrants, exercisable, period from completion of a merger	30 days
Warrants, exercisable, period from closing of IPO	12 months
Warrants expiration period	5 years
Redemption price of warrants (in usd per share)	$ 0.01
Redemption notice period	30 days
Redemption stock price trigger (in usd per share)	$ 18
Redemption stock price threshold trading days | day	20
Redemption stock price threshold consecutive trading days	30 days
Private Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares) | shares	3,950	3,950

Warrants and Forward Purchase_3

Warrants and Forward Purchase Share Agreements - Forward Share Purchase Agreements (Details) $ / shares in Units, shares in Thousands, $ in Thousands		2 Months Ended	3 Months Ended	9 Months Ended
	Aug. 01, 2022 USD ($) shares	Jan. 31, 2022 agreement $ / shares shares	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	May 03, 2022 $ / shares shares	Feb. 04, 2022 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares
Derivative [Line Items]
Number of FPAs | agreement		4
FPAs, number of shares (in shares) | shares		4,000
Restricted cash			$ 607	$ 607			$ 130
FPAs, term		3 months
Release of restricted cash from escrow			720	8,089
Purchase of treasury stock			0
Common
Derivative [Line Items]
Stock repurchased (in shares) | shares	3,081
Purchase of treasury stock	$ 31,663
Escrow deposit
Derivative [Line Items]
Restricted cash			$ 360	$ 360		$ 39,032
Escrow deposit | Common
Derivative [Line Items]
Restricted cash	$ 360
Derivative instrument, period, one
Derivative [Line Items]
FPAs, number of shares (in shares) | shares		2,600			2,404
FPAs, exercise price (in usd per share) | $ / shares		$ 10.16			$ 10.31
Derivative instrument, period, two
Derivative [Line Items]
FPAs, number of shares (in shares) | shares					686		1,400
FPAs, exercise price (in usd per share) | $ / shares					$ 10.16		$ 10.01

Equity Incentive Plans - Narrat

Equity Incentive Plans - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended	12 Months Ended
	Feb. 04, 2022 USD ($) day shares	May 31, 2021 $ / shares shares	Sep. 30, 2022 USD ($) plan $ / shares shares	Mar. 31, 2022 USD ($) shares	Sep. 30, 2022 USD ($) plan $ / shares shares	Dec. 31, 2021 USD ($) shares	Jan. 01, 2023 shares	Jun. 30, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity plans | plan			4		4
Options granted (in shares)			0		0
Options modified (in shares)	2,917
Options modified, expense | $				$ 1,366
Service-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $			$ 1,219		$ 1,219
Unrecognized compensation cost, recognition period					2 years 1 month 17 days
Market-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $			$ 1,687		$ 1,687
Unrecognized compensation cost, recognition period					1 year 6 months 18 days
Options outstanding (in shares)	1,458					1,458
Market capitalization target, threshold consecutive days	30 days
Market-based awards | Vesting tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	50%
Market-based awards | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	50%
Performance-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	1,458					1,458
Vesting percentage				33.33%
Performance-based awards | Vesting tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Revenue target one | $	$ 65,000					$ 75,000
Vesting percentage	50%
Revenue target percentage	90%
Performance-based awards | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Revenue target two | $	$ 101,000					150,000
Vesting percentage	50%
Revenue target percentage	90%
Performance-based awards | Vesting tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Revenue target three | $						$ 300,000
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)			101
Common stock reserved for issuance (in shares)	4,502
Granted (in usd per share) | $ / shares			$ 1.98
Options outstanding (in shares)			101		101			0
2021 Plan | Stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost | $			$ 114		$ 114
Unrecognized compensation cost, recognition period					3 years 4 months 9 days
Options granted, weighted average grant-date fair value (in usd per share) | $ / shares			$ 1.16		$ 1.16
2021 Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)			1,228
Total unrecognized compensation cost | $			$ 1,825		$ 1,825
Unrecognized compensation cost, recognition period					3 years 4 months 2 days
2021 Plan | Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance, annual increase percentage							10%
Common stock reserved for issuance, annual increase (in shares)							4,502
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)		2,191
Granted (in usd per share) | $ / shares		$ 1.10
Options outstanding (in shares)			3,534	3,681	3,534	3,851		3,649
2018 Plan | Service-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)			2,478		2,478
2018 Plan | Market-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)			1,056		1,056
Market capitalization target | $	$ 1,000,000
Market capitalization target, threshold days | day	20
Market capitalization target, threshold consecutive days	30 days
2018 Plan | Performance-based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)			0		0
Earn-Out Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)	571
Earn-Out Plan | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grants in period (in shares)					0

Equity Incentive Plans - Weight

Equity Incentive Plans - Weighted-Average Assumptions Used in Option Pricing Model (Details) - Stock Option	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	4.10%	4.10%
Expected term in years		4 years 21 days
Expected volatility	74.60%	74.60%
Expected dividend yield	0%	0%
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate			1%
Expected term in years			5 years 10 months 24 days
Expected volatility			61.20%
Expected dividend yield			0%

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended	3 Months Ended			9 Months Ended
	Feb. 04, 2022 USD ($) day shares	May 31, 2021 $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares
Number of Shares
Granted (in shares)			0			0
Performance-based awards
Number of Shares
Outstanding (in shares)					1,458	1,458
Outstanding (in shares)	1,458
Market-based awards
Number of Shares
Outstanding (in shares)					1,458	1,458
Outstanding (in shares)	1,458
Weighted Average Remaining Contractual Term (in years)
Market capitalization target, threshold consecutive days	30 days
2021 Plan
Number of Shares
Outstanding (in shares)			0
Granted (in shares)			101
Exercised (in shares)			0
Forfeited or expired (in shares)			0
Outstanding (in shares)			101	0		101
Vested and exercisable (in shares)			0			0
Weighted Average Exercise Price
Outstanding (in usd per share) | $ / shares			$ 0
Granted (in usd per share) | $ / shares			1.98
Exercised (in usd per share) | $ / shares			0
Forfeited or expired (in usd per share) | $ / shares			0
Outstanding (in usd per share) | $ / shares			1.98	$ 0		$ 1.98
Vested and exercisable (in usd per share) | $ / shares			$ 0			$ 0
Aggregate Intrinsic Value
Outstanding | $			$ 0	$ 0		$ 0
Vested and exercisable | $			$ 0			$ 0
Weighted Average Remaining Contractual Term (in years)
Outstanding			9 years 10 months 20 days	0 years
Vested and exercisable						0 years
2018 Plan
Number of Shares
Outstanding (in shares)			3,649	3,681	3,851	3,851
Granted (in shares)		2,191
Exercised (in shares)			(5)	(29)	(114)
Forfeited or expired (in shares)			(110)	(3)	(56)
Outstanding (in shares)			3,534	3,649	3,681	3,534
Vested and exercisable (in shares)			1,849			1,849
Weighted Average Exercise Price
Outstanding (in usd per share) | $ / shares			$ 1.78	$ 1.78	$ 1.77	$ 1.77
Granted (in usd per share) | $ / shares		$ 1.10
Exercised (in usd per share) | $ / shares			0.79	1.05	1.12
Forfeited or expired (in usd per share) | $ / shares			7.75	2.30	1.08
Outstanding (in usd per share) | $ / shares			1.60	$ 1.78	$ 1.78	1.60
Vested and exercisable (in usd per share) | $ / shares			$ 1.18			$ 1.18
Aggregate Intrinsic Value
Outstanding | $			$ 84	$ 11,307	$ 23,918	$ 84
Vested and exercisable | $			$ 82			$ 82
Weighted Average Remaining Contractual Term (in years)
Outstanding			8 years 3 months 14 days	8 years 4 months 6 days	8 years 7 months 13 days
Vested and exercisable						7 years 9 months 18 days
2018 Plan | Service-based awards
Number of Shares
Outstanding (in shares)			2,478			2,478
2018 Plan | Performance-based awards
Number of Shares
Outstanding (in shares)			0			0
2018 Plan | Market-based awards
Number of Shares
Outstanding (in shares)			1,056			1,056
Weighted Average Remaining Contractual Term (in years)
Market capitalization target | $	$ 1,000,000
Market capitalization target, threshold days | day	20
Market capitalization target, threshold consecutive days	30 days

Equity Incentive Plans - Restri

Equity Incentive Plans - Restricted Stock Unit (Details) - 2021 Plan - Restricted Stock Units (RSUs) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	0
Granted (in shares) | shares	1,228
Vested (in shares) | shares	(173)
Forfeited (in shares) | shares	(65)
Ending balance (in shares) | shares	990
Weighted Average Grant Date Fair Value
Beginning balance (in usd per share) | $ / shares	$ 0
Granted (in usd per share) | $ / shares	1.98
Vested (in usd per share) | $ / shares	1.98
Forfeited (in usd per share) | $ / shares	1.98
Ending balance (in usd per share) | $ / shares	$ 1.98
Granted, fair value | $	$ 2,432
Vested, fair value | $	$ 325

Equity Incentive Plans - Stock-

Equity Incentive Plans - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 771	$ 208	$ 3,159	$ 729
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	77	15	137	65
Product development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	86	14	123	126
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 608	$ 179	$ 2,899	$ 538

Employee Stock Purchase Plan (D

Employee Stock Purchase Plan (Details) - Employee Stock - shares shares in Thousands	Jan. 01, 2023	Feb. 04, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)		1,126
Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance, annual increase percentage	2.50%
Common stock reserved for issuance, annual increase (in shares)	1,126

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Aug. 31, 2021	Jun. 30, 2021
Related Party Transactions [Abstract]
Related party revenue	$ 0	$ 11	$ 0	$ 125
2021 Notes | Convertible Senior Notes
Related Party Transaction [Line Items]
Aggregate principal amount					$ 7,500	$ 23,970
Significant investor | 2021 Notes | Convertible Senior Notes
Related Party Transaction [Line Items]
Aggregate principal amount						$ 1,000

Defined Contribution Plan (Deta

Defined Contribution Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Retirement Benefits [Abstract]
Expense from matching contributions	$ 225	$ 159	$ 684	$ 528

Net Income (Loss) Per Share - N

Net Income (Loss) Per Share - Narrative (Details) - shares shares in Thousands	Sep. 30, 2022	Feb. 04, 2022
Sponsor, escrow shares
Schedule Of Reverse Recapitalization [Line Items]
Earn-out shares (in shares)	5,429	1,625

Net Income (Loss) Per Share - C

Net Income (Loss) Per Share - Computation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss)	$ 15,454	$ 14,759	$ (19,376)	$ (4,454)	$ (1,317)	$ (1,109)	$ 10,837	$ (6,880)
Income impact of FPAs	(3,939)			0			(346)	0
Income impact of convertible promissory notes	600			0			0	0
Total undistributed income (loss)	$ 12,115			$ (4,454)			$ 10,491	$ (6,880)
Weighted average shares outstanding (in shares)	35,580			24,923			35,260	24,832
Dilutive effect of FPAs (in shares)	3,547			0			1,140	0
Dilutive effect of convertible promissory notes (in shares)	2,477			0			0	0
Dilutive effect of stock-based awards (in shares)	1,611			0			2,304	0
Common stock and common stock equivalents (in shares)	43,215			24,923			38,704	24,832
Basic net income (loss) per share (in usd per share)	$ 0.43			$ (0.18)			$ 0.31	$ (0.28)
Diluted net income (loss) per share (in usd per share)	$ 0.28			$ (0.18)			$ 0.27	$ (0.28)
Common
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss)	$ 15,454						$ 10,837
Weighted average shares outstanding (in shares)	35,580						35,260
Common stock and common stock equivalents (in shares)	43,215						38,704
Basic net income (loss) per share (in usd per share)	$ 0.43						$ 0.31
Diluted net income (loss) per share (in usd per share)	$ 0.28						$ 0.27
Class 1
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss)				$ (1,676)				$ (2,598)
Weighted average shares outstanding (in shares)				9,379				9,379
Common stock and common stock equivalents (in shares)				9,379				9,379
Basic net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)
Diluted net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)
Class 2
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss)				$ (2,458)				$ (3,811)
Weighted average shares outstanding (in shares)				13,755				13,755
Common stock and common stock equivalents (in shares)				13,755				13,755
Basic net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)
Diluted net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)
Class 3
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income (loss)				$ (320)				$ (471)
Weighted average shares outstanding (in shares)				1,789				1,698
Common stock and common stock equivalents (in shares)				1,789				1,698
Basic net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)
Diluted net income (loss) per share (in usd per share)				$ (0.18)				$ (0.28)

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Antidilutive Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	18,561	22,166	20,989	22,166
Shares subject to warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	10,451	0	10,451	0
Shares subject to convertible promissory notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	0	12,240	2,428	12,240
Preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	0	6,141	0	6,141
Escrow Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	1,625	0	1,625	0
Shares subject to outstanding common stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	1,056	3,785	1,056	3,785
Shares subject to stockholder earn-out rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	5,429	0	5,429	0

Segment Reporting (Details)

Segment Reporting (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Revenue	$ 11,781	$ 10,896	$ 35,251	$ 30,959
Gross profit	10,266	9,635	30,840	27,395
Retail
Segment Reporting Information [Line Items]
Revenue	9,042	8,606	27,286	24,572
Gross profit	7,979	7,744	24,193	22,339
Brands
Segment Reporting Information [Line Items]
Revenue	2,739	2,290	7,965	6,387
Gross profit	$ 2,287	$ 1,891	$ 6,647	$ 5,056

Fair Value Measurements - Deriv

Fair Value Measurements - Derivative Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Aug. 01, 2022	Jun. 30, 2022	Feb. 04, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (loss)	$ 22,264	$ 0	$ 36,264	$ 0
Forward share purchase agreements derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability					$ 13,824
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	997		997			$ 37,084	$ 51,085
Gain (loss)	22,264		36,264
Level 3 | Private warrants derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	662		662			3,693	3,916
Gain (loss)	3,031		3,254
Level 3 | Forward share purchase agreements derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0		0			17,763	14,170
Gain (loss)	3,939		346
Level 3 | Escrow shares derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	47		47			3,481	6,868
Gain (loss)	3,434		6,821
Level 3 | Stockholder earn-out rights derivative liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	288		288			$ 12,147	$ 26,131
Gain (loss)	$ 11,859		$ 25,843

Fair Value Measurements - Valua

Fair Value Measurements - Valuation Assumptions (Details) uSD in Thousands		3 Months Ended
	Feb. 04, 2022 $ / shares uSD	Sep. 30, 2022 $ / shares uSD	Jun. 30, 2022 $ / shares uSD
Private warrants derivative liability | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	11.50	11.50	11.50
Private warrants derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	6.53	0.68	4.50
Private warrants derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.343	0.980	0.516
Private warrants derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	5 years	4 years 4 months 2 days	4 years 7 months 2 days
Private warrants derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.018	0.041	0.030
Private warrants derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0
Forward share purchase agreements derivative liability | Exercise price one
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	10.16		10.31
Forward share purchase agreements derivative liability | Exercise price two
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	10.01		10.16
Forward share purchase agreements derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	6.53		4.50
Forward share purchase agreements derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.639		0.704
Forward share purchase agreements derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	2 months 26 days		1 month 2 days
Forward share purchase agreements derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.002		0.013
Forward share purchase agreements derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0		0
Escrow shares derivative liability | First stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	13.50	13.50	13.50
Escrow shares derivative liability | Second stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	15.50	15.50	15.50
Escrow shares derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	6.53	0.68	4.50
Escrow shares derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.640	0.790	0.680
Escrow shares derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	3 years	2 years 4 months 2 days	2 years 7 months 2 days
Escrow shares derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.016	0.042	0.030
Escrow shares derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0
Stockholder earn-out rights derivative liability | First stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	13.50	13.50	13.50
Stockholder earn-out rights derivative liability | Second stock price trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	15.50	15.50	15.50
Stockholder earn-out rights derivative liability | First revenue trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | uSD	65,000	65,000	65,000
Stockholder earn-out rights derivative liability | Second revenue trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | uSD	101,000	101,000	101,000
Stockholder earn-out rights derivative liability | Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	6.53	0.68	4.50
Stockholder earn-out rights derivative liability | 2022 Revenue assumption
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | uSD	55,500	47,500	49,500
Stockholder earn-out rights derivative liability | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.640	0.790	0.680
Stockholder earn-out rights derivative liability | Term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative, term	3 years	2 years 4 months 2 days	2 years 7 months 2 days
Stockholder earn-out rights derivative liability | Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.016	0.042	0.030
Stockholder earn-out rights derivative liability | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0	0

Subsequent Events (Details)

Subsequent Events (Details) $ in Thousands		2 Months Ended	3 Months Ended
	Oct. 06, 2022 shares	Dec. 31, 2022 employee	Dec. 31, 2022 USD ($)
Forecast
Subsequent Event [Line Items]
Expected number of employees to be eliminated | employee		56
Restructuring charges | $			$ 500
Subsequent Event | Restricted stock units
Subsequent Event [Line Items]
Number of shares awarded	512,203
Subsequent Event | Performance-based units | Employee
Subsequent Event [Line Items]
Number of shares awarded	819,721